Quiver News

Senator Katie Britt discussed safeguarding minors against Big Tech and AI threats on CNN's State of the Union.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Katie Boyd Britt Fundraising

Katie Boyd Britt recently disclosed $273.1K of fundraising in a Q3 FEC disclosure filed on October 15th, 2025. This was the 347th most from all Q3 reports we have seen this year. 87.4% came from individual donors.

Britt disclosed $236.3K of spending. This was the 229th most from all Q3 reports we have seen from politicians so far this year.

Britt disclosed $5.2M of cash on hand at the end of the filing period. This was the 46th most from all Q3 reports we have seen this year.

You can see the disclosure here, or track Katie Boyd Britt's fundraising on Quiver Quantitative.

Katie Boyd Britt Net Worth

Quiver Quantitative estimates that Katie Boyd Britt is worth $7.0M, as of December 28th, 2025. This is the 139th highest net worth in Congress, per our live estimates.

Britt has approximately $3.9M invested in publicly traded assets which Quiver is able to track live.

You can track Katie Boyd Britt's net worth on Quiver Quantitative's politician page for Britt.

Katie Boyd Britt Bill Proposals

Here are some bills which have recently been proposed by Katie Boyd Britt:

• S.3411: A bill to amend the Securities Exchange Act of 1934 to specify that actions of the Advocate for Small Business Capital Formation are not a collection of information under the Paperwork Reduction Act.
• S.3254: NIH IMPROVE Act
• S.3177: Citizen Ballot Protection Act
• S.2924: Small Entity Update Act
• S.2636: A bill to prohibit individuals who are not citizens of the United States from voting in elections in the District of Columbia and to repeal the Local Resident Voting Rights Amendment Act of 2022.
• S.2544: GUARD Act

You can track bills proposed by Katie Boyd Britt on Quiver Quantitative's politician page for Britt.

AI Growth Sparks Buzz: Recent discussions on social media about Broadcom Inc. have centered on its impressive AI-driven growth. Many users highlight the company’s $73 billion AI order backlog, viewing it as a strong indicator of future revenue. The stock’s 52% year-to-date surge has fueled excitement among investors.

Post-Earnings Drop Concerns: Despite blockbuster Q4 earnings, chatter reflects unease over a sharp 15-21% stock price drop post-report. Some point to flat non-AI revenue guidance as a reason for the reversal, raising questions about broader growth sustainability. Others still see long-term potential in AI and networking sectors.

Analyst Optimism for 2026: Conversations also note positive analyst forecasts for 2026, with many emphasizing Broadcom’s role in custom silicon for AI. A recent 10% dividend hike is often mentioned as a sign of confidence. The tone suggests hope for recovery despite short-term volatility.

Note: This discussion summary was generated from an AI condensation of post data.

Broadcom Inc. Insider Trading Activity

Broadcom Inc. insiders have traded $AVGO stock on the open market 175 times in the past 6 months. Of those trades, 4 have been purchases and 171 have been sales.

Here’s a breakdown of recent trading of $AVGO stock by insiders over the last 6 months:

• HENRY SAMUELI has made 0 purchases and 16 sales selling 689,113 shares for an estimated $252,917,774.
• HOCK E TAN (President and CEO) has made 0 purchases and 4 sales selling 378,154 shares for an estimated $126,220,000.
• MARK DAVID BRAZEAL (Chief Legal & Corp Affairs Ofc) has made 0 purchases and 58 sales selling 90,012 shares for an estimated $30,496,501.
• KIRSTEN M. SPEARS (CFO & Chief Accounting Officer) has made 0 purchases and 44 sales selling 18,412 shares for an estimated $6,372,620.
• CHARLIE B KAWWAS (President, Semi Solutions Grp) has made 0 purchases and 43 sales selling 9,560 shares for an estimated $3,309,571.
• JUSTINE PAGE has made 0 purchases and 6 sales selling 4,800 shares for an estimated $1,587,952.
• HARRY L. YOU has made 4 purchases buying 4,550 shares for an estimated $1,552,999 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Broadcom Inc. Revenue

Broadcom Inc. had revenues of $18B in Q4 2025. This is an increase of 28.18% from the same period in the prior year.

You can track AVGO financials on Quiver Quantitative's AVGO stock page.

Broadcom Inc. Congressional Stock Trading

Members of Congress have traded $AVGO stock 18 times in the past 6 months. Of those trades, 12 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $AVGO stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 3 purchases worth up to $80,000 on 10/10 and 0 sales.
• REPRESENTATIVE VAL T. HOYLE sold up to $50,000 on 09/23.
• REPRESENTATIVE CLEO FIELDS has traded it 6 times. They made 6 purchases worth up to $315,000 on 09/17, 08/15, 08/13, 07/29, 07/18 and 0 sales.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 07/18.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
• REPRESENTATIVE JAMES COMER sold up to $15,000 on 07/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Broadcom Inc. Hedge Fund Activity

We have seen 2,095 institutional investors add shares of Broadcom Inc. stock to their portfolio, and 1,950 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 31,423,170 shares (+78.8%) to their portfolio in Q3 2025, for an estimated $10,366,818,014
• CAPITAL WORLD INVESTORS removed 12,713,939 shares (-8.6%) from their portfolio in Q3 2025, for an estimated $4,194,455,615
• WELLINGTON MANAGEMENT GROUP LLP removed 10,906,362 shares (-19.0%) from their portfolio in Q3 2025, for an estimated $3,598,117,887
• NORGES BANK removed 5,462,267 shares (-7.5%) from their portfolio in Q2 2025, for an estimated $1,505,673,898
• BNP PARIBAS FINANCIAL MARKETS removed 5,416,301 shares (-47.9%) from their portfolio in Q3 2025, for an estimated $1,786,891,862
• BANK OF AMERICA CORP /DE/ removed 5,123,905 shares (-7.6%) from their portfolio in Q3 2025, for an estimated $1,690,427,498
• PRICE T ROWE ASSOCIATES INC /MD/ added 4,904,436 shares (+6.3%) to their portfolio in Q3 2025, for an estimated $1,618,022,480

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Broadcom Inc. Government Contracts

We have seen $67,073,179 of award payments to $AVGO over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• NEW 66 MONTH OPEN-MARKET CONTRACT FOR RENEWAL OF CA SOFTWARE, SUPPORT SERVICES, AND MAINTENANCE. CA PROPRIE...: $41,249,999
• CA SOFTWARE MAINTENANCE: $21,091,011
• BROADCOM TECHNICAL SUPPORT SERVICES INDEFINITE DELIVERY/INDEFINITE QUANTITY (IDIQ) CONTRACT - TASK ORDER F...: $3,629,376
• BROADCOM IDIQ TASK ORDER FOR CLARITY INVESTMENT MANAGEMENT TOOL (IMT) SUPPORT SERVICES.: $885,600
• BROADCOM TECHNICAL SUPPORT SERVICES INDEFINITE DELIVERY/INDEFINITE QUANTITY (IDIQ) CONTRACT - TASK ORDER F...: $170,880

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Broadcom Inc. Analyst Ratings

Wall Street analysts have issued reports on $AVGO in the last several months. We have seen 16 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 12/12/2025
• Oppenheimer issued a "Outperform" rating on 12/12/2025
• Piper Sandler issued a "Overweight" rating on 12/12/2025
• Rosenblatt issued a "Buy" rating on 12/12/2025
• Benchmark issued a "Buy" rating on 12/12/2025
• Bernstein issued a "Outperform" rating on 12/12/2025
• Morgan Stanley issued a "Overweight" rating on 12/01/2025

To track analyst ratings and price targets for Broadcom Inc., check out Quiver Quantitative's $AVGO forecast page.

Broadcom Inc. Price Targets

Multiple analysts have issued price targets for $AVGO recently. We have seen 22 analysts offer price targets for $AVGO in the last 6 months, with a median target of $450.0.

Here are some recent targets:

• William Stein from Truist Securities set a target price of $510.0 on 12/19/2025
• Timothy Arcuri from UBS set a target price of $475.0 on 12/15/2025
• Vivek Arya from B of A Securities set a target price of $500.0 on 12/12/2025
• John Vinh from Keybanc set a target price of $500.0 on 12/12/2025
• Christopher Danely from Citigroup set a target price of $480.0 on 12/12/2025
• Vijay Rakesh from Mizuho set a target price of $450.0 on 12/12/2025
• Rick Schafer from Oppenheimer set a target price of $450.0 on 12/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

BlueBird 6 Launch Hype: Recent chatter on social media has centered around AST SpaceMobile's BlueBird 6 satellite launch, which took place around Christmas Eve. Many are thrilled about this potential milestone for the company’s direct-to-smartphone broadband network. The stock’s 15% surge prior to the launch added fuel to the excitement.

Insider Sales Concerns: Despite the optimism, some frustration persists over delays in the BlueBird 6 timeline and recent insider share sales. A few voices remain hopeful, focusing on the long-term vision of global connectivity. Others question whether these insider moves signal a lack of confidence among key stakeholders.

Note: This discussion summary was generated from an AI condensation of post data.

AST SpaceMobile Insider Trading Activity

AST SpaceMobile insiders have traded $ASTS stock on the open market 12 times in the past 6 months. Of those trades, 4 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $ASTS stock by insiders over the last 6 months:

• TOWER CORP /MA/ AMERICAN sold 2,288,621 shares for an estimated $159,631,314
• HUIWEN YAO (Chief Technology Officer) has made 0 purchases and 3 sales selling 96,000 shares for an estimated $5,332,640.
• ANDREW MARTIN JOHNSON (CFO and CLO) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $1,609,610.
• SHANTI B. GUPTA (Chief Operating Officer) sold 10,000 shares for an estimated $773,400
• MAYA BERNAL (Chief Accounting Officer) sold 6,000 shares for an estimated $442,560
• KEITH R LARSON has made 2 purchases buying 1,390 shares for an estimated $99,143 and 0 sales.
• ADRIANA CISNEROS has made 2 purchases buying 750 shares for an estimated $38,092 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AST SpaceMobile Revenue

AST SpaceMobile had revenues of $14.7M in Q3 2025. This is an increase of 1239.91% from the same period in the prior year.

You can track ASTS financials on Quiver Quantitative's ASTS stock page.

AST SpaceMobile Hedge Fund Activity

We have seen 266 institutional investors add shares of AST SpaceMobile stock to their portfolio, and 169 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• D. E. SHAW & CO., INC. removed 2,599,151 shares (-44.1%) from their portfolio in Q3 2025, for an estimated $127,566,331
• VANGUARD GROUP INC added 2,351,539 shares (+13.4%) to their portfolio in Q3 2025, for an estimated $115,413,534
• UBS GROUP AG added 1,834,529 shares (+86.9%) to their portfolio in Q3 2025, for an estimated $90,038,683
• WELLS FARGO & COMPANY/MN added 1,674,499 shares (+1302.7%) to their portfolio in Q3 2025, for an estimated $82,184,410
• MAREX GROUP PLC added 1,044,221 shares (+450.5%) to their portfolio in Q3 2025, for an estimated $51,250,366
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 967,826 shares (+38.1%) to their portfolio in Q3 2025, for an estimated $47,500,900
• MORGAN STANLEY removed 912,357 shares (-22.0%) from their portfolio in Q3 2025, for an estimated $44,778,481

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AST SpaceMobile Analyst Ratings

Wall Street analysts have issued reports on $ASTS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• B. Riley Securities issued a "Buy" rating on 10/23/2025
• Barclays issued a "Underweight" rating on 10/17/2025

To track analyst ratings and price targets for AST SpaceMobile, check out Quiver Quantitative's $ASTS forecast page.

AST SpaceMobile Price Targets

Multiple analysts have issued price targets for $ASTS recently. We have seen 5 analysts offer price targets for $ASTS in the last 6 months, with a median target of $60.0.

Here are some recent targets:

• Andres Coello from Scotiabank set a target price of $45.6 on 11/25/2025
• Greg Pendy from Clear Street set a target price of $87.0 on 11/12/2025
• Mike Crawford from B. Riley Securities set a target price of $95.0 on 10/23/2025
• Mathieu Robilliard from Barclays set a target price of $60.0 on 10/17/2025
• Christopher Schoell from UBS set a target price of $43.0 on 09/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Quantum Breakthroughs: Recent chatter on social media about IonQ has focused on its latest advancements in quantum computing. Many are buzzing about a significant sale of a 100-qubit system to South Korea, seeing it as a milestone for the company. The excitement hints at growing faith in IonQ’s potential to lead the quantum space.

Market Concerns: Despite the enthusiasm, there’s also notable concern over recent stock price dips, with some discussions pointing to a 7% drop amid holiday trading. Posts reflect skepticism about whether current valuations match the company’s real-world progress. This mix of optimism and doubt keeps the conversation lively.

Future Outlook: Another hot topic is IonQ’s long-term positioning, with some highlighting partnerships with tech giants as a sign of strength. However, others question the reliability of its systems and the sustainability of its market cap. The debate continues to spark interest among followers of quantum tech stocks.

Note: This discussion summary was generated from an AI condensation of post data.

IonQ Insider Trading Activity

IonQ insiders have traded $IONQ stock on the open market 18 times in the past 6 months. Of those trades, 1 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $IONQ stock by insiders over the last 6 months:

• THOMAS G. KRAMER (Chief Financial Officer) has made 0 purchases and 5 sales selling 245,214 shares for an estimated $10,812,358.
• RIMA ALAMEDDINE (Chief Revenue Officer) has made 0 purchases and 3 sales selling 164,976 shares for an estimated $7,654,126.
• INDER M SINGH has made 0 purchases and 2 sales selling 87,570 shares for an estimated $3,591,691.
• KATHRYN K. CHOU has made 0 purchases and 4 sales selling 36,789 shares for an estimated $1,826,743.
• MASI NICCOLO DE (President and CEO) sold 16,120 shares for an estimated $715,753
• ROBERT T. CARDILLO sold 8,773 shares for an estimated $443,191
• PAUL T DACIER (Chief Administrative Officer) sold 4,175 shares for an estimated $185,376
• WILLIAM J JR TEUBER purchased 2,000 shares for an estimated $109,630

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

IonQ Revenue

IonQ had revenues of $39.9M in Q3 2025. This is an increase of 221.5% from the same period in the prior year.

You can track IONQ financials on Quiver Quantitative's IONQ stock page.

IonQ Hedge Fund Activity

We have seen 453 institutional investors add shares of IonQ stock to their portfolio, and 165 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MORGAN STANLEY added 6,056,793 shares (+29.9%) to their portfolio in Q3 2025, for an estimated $372,492,769
• VANGUARD GROUP INC added 4,587,260 shares (+18.5%) to their portfolio in Q3 2025, for an estimated $282,116,490
• BLACKROCK, INC. added 4,225,572 shares (+23.1%) to their portfolio in Q3 2025, for an estimated $259,872,678
• RENAISSANCE TECHNOLOGIES LLC added 4,073,300 shares (+404.7%) to their portfolio in Q3 2025, for an estimated $250,507,950
• NORGES BANK added 2,524,895 shares (+1729.7%) to their portfolio in Q2 2025, for an estimated $108,494,738
• CERBERUS CAPITAL MANAGEMENT, L.P. removed 2,306,359 shares (-94.8%) from their portfolio in Q3 2025, for an estimated $141,841,078
• PRICE T ROWE ASSOCIATES INC /MD/ added 1,771,652 shares (+120.1%) to their portfolio in Q3 2025, for an estimated $108,956,598

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

IonQ Analyst Ratings

Wall Street analysts have issued reports on $IONQ in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wedbush issued a "Outperform" rating on 12/17/2025
• Mizuho issued a "Outperform" rating on 12/11/2025
• Cantor Fitzgerald issued a "Overweight" rating on 11/07/2025
• Rosenblatt issued a "Buy" rating on 11/06/2025
• Needham issued a "Buy" rating on 11/06/2025
• Benchmark issued a "Buy" rating on 09/16/2025
• B. Riley Securities issued a "Buy" rating on 09/15/2025

To track analyst ratings and price targets for IonQ, check out Quiver Quantitative's $IONQ forecast page.

IonQ Price Targets

Multiple analysts have issued price targets for $IONQ recently. We have seen 12 analysts offer price targets for $IONQ in the last 6 months, with a median target of $72.5.

Here are some recent targets:

• Antoine Legault from Wedbush set a target price of $60.0 on 12/17/2025
• Kevin Garrigan from Jefferies set a target price of $100.0 on 12/16/2025
• Vijay Rakesh from Mizuho set a target price of $90.0 on 12/11/2025
• Peter Peng from JP Morgan set a target price of $47.0 on 11/20/2025
• Troy Jensen from Cantor Fitzgerald set a target price of $70.0 on 11/07/2025
• N. Quinn Bolton from Needham set a target price of $80.0 on 11/06/2025
• Alex Platt from DA Davidson set a target price of $55.0 on 11/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Robotaxi Rollout Buzz: Recent chatter on social media about Tesla, Inc. has centered on the company’s ambitious robotaxi initiative. Many are excited about the potential for autonomous fleets to revolutionize transportation, with some users highlighting accelerated testing and hiring efforts. However, skepticism remains as others point out regulatory hurdles and delays in achieving unsupervised full self-driving capabilities.

Sales Slump Concerns: Another hot topic is Tesla’s sales performance, particularly a reported decline in key markets like China and the U.S. Social media discussions reflect worry over softening demand and fierce competition from rivals, with some fearing a challenging end to 2025. A few voices still express optimism, citing upcoming affordable models as a potential boost for future growth.

Note: This discussion summary was generated from an AI condensation of post data.

Tesla, Inc. Insider Trading Activity

Tesla, Inc. insiders have traded $TSLA stock on the open market 38 times in the past 6 months. Of those trades, 25 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $TSLA stock by insiders over the last 6 months:

• ELON MUSK (CEO) has made 25 purchases buying 2,568,732 shares for an estimated $999,959,042 and 0 sales.
• JAMES R MURDOCH has made 0 purchases and 2 sales selling 180,000 shares for an estimated $67,395,120.
• KIMBAL MUSK sold 56,820 shares for an estimated $25,606,501
• XIAOTONG ZHU (SVP, APAC and) sold 20,000 shares for an estimated $7,275,100
• VAIBHAV TANEJA (Chief Financial Officer) has made 0 purchases and 9 sales selling 11,242 shares for an estimated $3,860,316.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Tesla, Inc. Revenue

Tesla, Inc. had revenues of $28.1B in Q3 2025. This is an increase of 11.57% from the same period in the prior year.

You can track TSLA financials on Quiver Quantitative's TSLA stock page.

Tesla, Inc. Congressional Stock Trading

Members of Congress have traded $TSLA stock 10 times in the past 6 months. Of those trades, 6 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $TSLA stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 3 purchases worth up to $45,000 on 11/18, 10/17, 08/05 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 5 times. They made 2 purchases worth up to $30,000 on 10/30, 09/11 and 3 sales worth up to $45,000 on 10/31, 10/30, 07/10.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/15.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Tesla, Inc. Hedge Fund Activity

We have seen 2,089 institutional investors add shares of Tesla, Inc. stock to their portfolio, and 1,657 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 14,840,290 shares (+59.9%) to their portfolio in Q3 2025, for an estimated $6,599,773,768
• MORGAN STANLEY removed 7,090,349 shares (-16.4%) from their portfolio in Q3 2025, for an estimated $3,153,220,007
• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 6,435,658 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,862,065,825
• FMR LLC added 6,195,054 shares (+20.7%) to their portfolio in Q3 2025, for an estimated $2,755,064,414
• BANK OF AMERICA CORP /DE/ removed 6,134,966 shares (-23.6%) from their portfolio in Q3 2025, for an estimated $2,728,342,079
• BARCLAYS PLC removed 4,190,432 shares (-20.4%) from their portfolio in Q3 2025, for an estimated $1,863,568,919
• VALEO FINANCIAL ADVISORS, LLC removed 3,773,499 shares (-98.4%) from their portfolio in Q3 2025, for an estimated $1,678,150,475

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Tesla, Inc. Government Contracts

We have seen $17,357 of award payments to $TSLA over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• AUTOMOTIVE MECHANICAL REPAIRS: $17,357

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Tesla, Inc. Analyst Ratings

Wall Street analysts have issued reports on $TSLA in the last several months. We have seen 10 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

• Deutsche Bank issued a "Buy" rating on 12/19/2025
• Wedbush issued a "Outperform" rating on 12/15/2025
• Mizuho issued a "Outperform" rating on 11/25/2025
• Stifel issued a "Buy" rating on 11/17/2025
• Cantor Fitzgerald issued a "Overweight" rating on 10/27/2025
• Canaccord Genuity issued a "Buy" rating on 10/23/2025
• GLJ Research issued a "Sell" rating on 10/22/2025

To track analyst ratings and price targets for Tesla, Inc., check out Quiver Quantitative's $TSLA forecast page.

Tesla, Inc. Price Targets

Multiple analysts have issued price targets for $TSLA recently. We have seen 24 analysts offer price targets for $TSLA in the last 6 months, with a median target of $473.0.

Here are some recent targets:

• George Gianarikas from Canaccord Genuity set a target price of $551.0 on 12/23/2025
• William Stein from Truist Securities set a target price of $444.0 on 12/19/2025
• Edison Yu from Deutsche Bank set a target price of $500.0 on 12/19/2025
• Dan Ives from Wedbush set a target price of $600.0 on 12/15/2025
• Alexander Potter from Piper Sandler set a target price of $500.0 on 12/09/2025
• Adam Jonas from Morgan Stanley set a target price of $425.0 on 12/08/2025
• Vijay Rakesh from Mizuho set a target price of $475.0 on 11/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

FDA Clearance Buzz: Recent chatter on social media has centered on Tempus AI, Inc.'s FDA 510(k) clearance for its AI-driven diagnostic tools. Many see this as a major milestone for precision medicine, particularly in oncology. The excitement suggests a belief in the company’s growth potential in the healthcare AI sector.

Stock Price Concerns: Alongside the positive news, discussions also focus on a recent 9% drop in TEM’s stock price. Some users express cautious optimism, noting technical patterns that could signal a rebound. Others remain skeptical until the stock stabilizes above key resistance levels.

Note: This discussion summary was generated from an AI condensation of post data.

Tempus AI, Inc. Insider Trading Activity

Tempus AI, Inc. insiders have traded $TEM stock on the open market 121 times in the past 6 months. Of those trades, 0 have been purchases and 121 have been sales.

Here’s a breakdown of recent trading of $TEM stock by insiders over the last 6 months:

• ERIC P LEFKOFSKY (CEO and Chairman) has made 0 purchases and 66 sales selling 1,696,787 shares for an estimated $127,005,580.
• THEODORE LEONSIS has made 0 purchases and 2 sales selling 64,000 shares for an estimated $4,592,200.
• RYAN FUKUSHIMA (Chief Operating Officer) has made 0 purchases and 20 sales selling 57,559 shares for an estimated $4,308,740.
• JAMES WILLIAM ROGERS (Chief Financial Officer) has made 0 purchases and 7 sales selling 34,751 shares for an estimated $2,499,084.
• ANDREW POLOVIN (EVP and General Counsel) has made 0 purchases and 9 sales selling 29,864 shares for an estimated $2,144,365.
• ERIK PHELPS (EVP & Chief Admin & Legal Off) has made 0 purchases and 5 sales selling 8,499 shares for an estimated $592,859.
• WAYNE A.I. FREDERICK sold 3,675 shares for an estimated $283,820
• RYAN M BARTOLUCCI (Chief Accounting Officer) has made 0 purchases and 4 sales selling 3,738 shares for an estimated $262,337.
• JENNIFER A DOUDNA has made 0 purchases and 3 sales selling 3,227 shares for an estimated $227,759.
• DAVID R EPSTEIN has made 0 purchases and 4 sales selling 1,240 shares for an estimated $91,006.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Tempus AI, Inc. Revenue

Tempus AI, Inc. had revenues of $334.2M in Q3 2025. This is an increase of 84.72% from the same period in the prior year.

You can track TEM financials on Quiver Quantitative's TEM stock page.

Tempus AI, Inc. Hedge Fund Activity

We have seen 253 institutional investors add shares of Tempus AI, Inc. stock to their portfolio, and 169 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GOLDMAN SACHS GROUP INC removed 4,030,697 shares (-94.7%) from their portfolio in Q3 2025, for an estimated $325,317,554
• NEA MANAGEMENT COMPANY, LLC removed 2,615,979 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $166,219,305
• BLACKROCK, INC. added 2,597,838 shares (+62.8%) to their portfolio in Q3 2025, for an estimated $209,671,504
• BAILLIE GIFFORD & CO removed 2,401,588 shares (-19.9%) from their portfolio in Q3 2025, for an estimated $193,832,167
• VANGUARD GROUP INC added 1,706,837 shares (+22.1%) to their portfolio in Q3 2025, for an estimated $137,758,814
• D. E. SHAW & CO., INC. added 1,605,757 shares (+380.8%) to their portfolio in Q3 2025, for an estimated $129,600,647
• BANK OF AMERICA CORP /DE/ added 1,277,244 shares (+112.9%) to their portfolio in Q3 2025, for an estimated $103,086,363

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Tempus AI, Inc. Government Contracts

We have seen $18,460,020 of award payments to $TEM over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• ADAPT CRO SUPPORT SERVICES SOLICITATION: $12,741,975
• TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES: $5,718,045

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Tempus AI, Inc. Analyst Ratings

Wall Street analysts have issued reports on $TEM in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Canaccord Genuity issued a "Buy" rating on 12/22/2025
• BTIG issued a "Buy" rating on 11/25/2025
• Morgan Stanley issued a "Overweight" rating on 11/11/2025
• HC Wainwright & Co. issued a "Buy" rating on 11/07/2025
• Guggenheim issued a "Buy" rating on 09/26/2025

To track analyst ratings and price targets for Tempus AI, Inc., check out Quiver Quantitative's $TEM forecast page.

Tempus AI, Inc. Price Targets

Multiple analysts have issued price targets for $TEM recently. We have seen 8 analysts offer price targets for $TEM in the last 6 months, with a median target of $87.0.

Here are some recent targets:

• Kyle Mikson from Canaccord Genuity set a target price of $80.0 on 12/22/2025
• Casey Woodring from JP Morgan set a target price of $80.0 on 12/15/2025
• Tejas Savant from Morgan Stanley set a target price of $85.0 on 12/02/2025
• Mark Massaro from BTIG set a target price of $105.0 on 11/25/2025
• David Westenberg from Piper Sandler set a target price of $80.0 on 11/11/2025
• Yi Chen from HC Wainwright & Co. set a target price of $89.0 on 11/07/2025
• Ryan MacDonald from Needham set a target price of $100.0 on 11/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent Price Decline: Social media has been abuzz with talk of BigBear.ai Holdings’ recent stock price drop, with some noting a decline of over 6% in a single day. Many attribute this to weaker-than-expected revenue figures and negative EBITDA, sparking worry among investors. There’s also unease about potential share dilution tied to a proposed increase in authorized shares.

Strategic Pivot to AI: Alongside financial concerns, discussions highlight the company’s bold shift toward sovereign AI and defense-grade software. Some see potential in catalysts like the Ask Sage deal, while others question if dilution risks will overshadow any gains. The mix of hope and skepticism keeps the conversation lively.

Note: This discussion summary was generated from an AI condensation of post data.

BigBear.ai Holdings Insider Trading Activity

BigBear.ai Holdings insiders have traded $BBAI stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $BBAI stock by insiders over the last 6 months:

• DOROTHY D HAYES has made 0 purchases and 2 sales selling 52,000 shares for an estimated $308,770.
• SEAN RAYMOND RICKER (Chief Financial Officer) has made 0 purchases and 3 sales selling 16,980 shares for an estimated $99,388.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BigBear.ai Holdings Revenue

BigBear.ai Holdings had revenues of $33.1M in Q3 2025. This is a decrease of -20.15% from the same period in the prior year.

You can track BBAI financials on Quiver Quantitative's BBAI stock page.

BigBear.ai Holdings Congressional Stock Trading

Members of Congress have traded $BBAI stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BBAI stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN purchased up to $50,000 on 08/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BigBear.ai Holdings Hedge Fund Activity

We have seen 207 institutional investors add shares of BigBear.ai Holdings stock to their portfolio, and 127 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• AE INDUSTRIAL PARTNERS, LP removed 27,430,402 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $186,252,429
• VANGUARD GROUP INC added 6,790,890 shares (+32.6%) to their portfolio in Q3 2025, for an estimated $44,276,602
• JUMP FINANCIAL, LLC removed 5,509,104 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $35,919,358
• MAREX GROUP PLC added 5,033,668 shares (+2421.6%) to their portfolio in Q3 2025, for an estimated $32,819,515
• BLACKROCK, INC. added 3,619,539 shares (+18.0%) to their portfolio in Q3 2025, for an estimated $23,599,394
• RENAISSANCE TECHNOLOGIES LLC removed 3,257,500 shares (-58.7%) from their portfolio in Q3 2025, for an estimated $21,238,900
• TWO SIGMA INVESTMENTS, LP added 3,056,597 shares (+165.5%) to their portfolio in Q3 2025, for an estimated $19,929,012

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BigBear.ai Holdings Government Contracts

We have seen $3,538,284 of award payments to $BBAI over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• COMMERICAL SOLUTIONS OPENING (CSO) FROM TRADEWINDS SOLUTIONS MARKETPLACE FOR THE ORION DECISION SUPPORT PLA...: $2,845,394
• BUSINESS REQUIREMENT SUPPORT: $692,889

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

BigBear.ai Holdings Analyst Ratings

Wall Street analysts have issued reports on $BBAI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 08/12/2025

To track analyst ratings and price targets for BigBear.ai Holdings, check out Quiver Quantitative's $BBAI forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

AI Growth Sparks Buzz: Recent chatter on social media has centered on Palantir Technologies' remarkable momentum in the AI sector. Many users are highlighting the company's rapid revenue growth and innovative AI solutions as key drivers of its stock performance. There's also excitement around new contracts and partnerships that could fuel further expansion.

Valuation Concerns Emerge: Despite the enthusiasm, some discussions point to concerns over the stock's high valuation. A segment of the online crowd warns that the current price may not fully align with future risks, echoing recent analyst scrutiny reported on platforms like CNBC. The divide in opinions keeps the conversation lively and dynamic.

Note: This discussion summary was generated from an AI condensation of post data.

Palantir Technologies Insider Trading Activity

Palantir Technologies insiders have traded $PLTR stock on the open market 337 times in the past 6 months. Of those trades, 0 have been purchases and 337 have been sales.

Here’s a breakdown of recent trading of $PLTR stock by insiders over the last 6 months:

• ALEXANDER C. KARP (See Remarks) has made 0 purchases and 40 sales selling 813,961 shares for an estimated $128,780,320.
• SHYAM SANKAR (See Remarks) has made 0 purchases and 61 sales selling 744,737 shares for an estimated $115,236,197.
• STEPHEN ANDREW COHEN (See Remarks) has made 0 purchases and 40 sales selling 699,655 shares for an estimated $110,692,932.
• RYAN D. TAYLOR (See Remarks) has made 0 purchases and 52 sales selling 209,016 shares for an estimated $32,689,604.
• ALEXANDER D. MOORE has made 0 purchases and 39 sales selling 120,000 shares for an estimated $19,958,898.
• DAVID A. GLAZER (See Remarks) has made 0 purchases and 49 sales selling 125,210 shares for an estimated $19,755,844.
• LAUREN ELAINA FRIEDMAN STAT has made 0 purchases and 7 sales selling 31,600 shares for an estimated $5,344,066.
• JEFFREY BUCKLEY (See Remarks) has made 0 purchases and 42 sales selling 9,085 shares for an estimated $1,434,669.
• ERIC H. WOERSCHING has made 0 purchases and 7 sales selling 10,214 shares for an estimated $1,337,545.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Palantir Technologies Revenue

Palantir Technologies had revenues of $1.2B in Q3 2025. This is an increase of 62.79% from the same period in the prior year.

You can track PLTR financials on Quiver Quantitative's PLTR stock page.

Palantir Technologies Congressional Stock Trading

Members of Congress have traded $PLTR stock 13 times in the past 6 months. Of those trades, 10 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $PLTR stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 3 purchases worth up to $45,000 on 11/18, 11/07, 10/09 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
• REPRESENTATIVE CLEO FIELDS has traded it 5 times. They made 5 purchases worth up to $600,000 on 10/10, 08/13, 07/28, 07/18, 06/30 and 0 sales.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 07/15.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 06/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Palantir Technologies Hedge Fund Activity

We have seen 1,603 institutional investors add shares of Palantir Technologies stock to their portfolio, and 1,170 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 18,622,083 shares (-99.8%) from their portfolio in Q3 2025, for an estimated $3,397,040,380
• JPMORGAN CHASE & CO added 18,587,777 shares (+115.6%) to their portfolio in Q3 2025, for an estimated $3,390,782,280
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 16,020,379 shares (+107.0%) to their portfolio in Q3 2025, for an estimated $2,922,437,537
• BLACKROCK, INC. added 11,275,223 shares (+6.4%) to their portfolio in Q3 2025, for an estimated $2,056,826,179
• VANGUARD GROUP INC added 8,168,604 shares (+4.0%) to their portfolio in Q3 2025, for an estimated $1,490,116,741
• STATE STREET CORP added 6,777,771 shares (+7.2%) to their portfolio in Q3 2025, for an estimated $1,236,400,985
• NORGES BANK added 6,277,645 shares (+34.9%) to their portfolio in Q2 2025, for an estimated $855,768,566

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Palantir Technologies Government Contracts

We have seen $691,617,262 of award payments to $PLTR over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• TASK ORDER #1 FOR MAVEN SMART SYSTEM - USER INTERFACE/USER EXPERIENCE (UI/UX) PROTOTYPE: $114,422,914
• INVESTIGATIVE CASE MANAGEMENT (ICM) OPERATIONS AND MAINTENANCE (O&M) SUPPORT SERVICES AND CUSTOM ENHANCEMENTS: $81,116,690
• SOFTWARE AS A SERVICE (SAAS) MODEL OF ARMY VANTAGE ON BEHALF OF PEO EIS, PDM ADP. ARMY VANTAGE IS THE ARMY'...: $68,048,339
• TASK ORDER OFF A COMMERCIAL SOLUTIONS OPENING (CSO) FOR RESEARCH AND DEVELOPMENT FOR MAVEN SMART SYSTEM (MS...: $37,874,170
• DATA SOFTWARE SERVICES (DSS) MULTIPLE AWARD IDIQ CONTRACT DELIVERY ORDER FOR HAF DATA PLATFORM REQUIREMENTS.: $33,551,421

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Palantir Technologies Analyst Ratings

Wall Street analysts have issued reports on $PLTR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• B of A Securities issued a "Buy" rating on 11/04/2025
• RBC Capital issued a "Underperform" rating on 11/04/2025
• Piper Sandler issued a "Overweight" rating on 11/04/2025
• Loop Capital issued a "Buy" rating on 07/30/2025

To track analyst ratings and price targets for Palantir Technologies, check out Quiver Quantitative's $PLTR forecast page.

Palantir Technologies Price Targets

Multiple analysts have issued price targets for $PLTR recently. We have seen 15 analysts offer price targets for $PLTR in the last 6 months, with a median target of $200.0.

Here are some recent targets:

• Rishi Jaluria from RBC Capital set a target price of $50.0 on 11/04/2025
• Sanjit Singh from Morgan Stanley set a target price of $205.0 on 11/04/2025
• Matthew Broome from Mizuho set a target price of $205.0 on 11/04/2025
• Clarke Jeffries from Piper Sandler set a target price of $225.0 on 11/04/2025
• Thomas Blakey from Cantor Fitzgerald set a target price of $198.0 on 11/04/2025
• Karl Keirstead from UBS set a target price of $205.0 on 11/04/2025
• Gil Luria from DA Davidson set a target price of $215.0 on 11/04/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

AI and Cloud Growth: Recent chatter on social media has been buzzing about Amazon's aggressive expansion in AI and cloud computing through its AWS division. Many are pointing to a reported 20% growth in AWS revenue as a sign of strong momentum, driven by AI workloads. There's also excitement over a potential $10 billion investment in OpenAI, fueling speculation about future innovation.

Retail and Holiday Performance: Another focal point online is Amazon’s retail strength, especially with record holiday sales being highlighted. Discussions note expanded same-day delivery for groceries and a significant push into warehouse automation as key drivers. However, some raise concerns about heavy spending and its impact on short-term cash flow.

Note: This discussion summary was generated from an AI condensation of post data.

Amazon Insider Trading Activity

Amazon insiders have traded $AMZN stock on the open market 71 times in the past 6 months. Of those trades, 0 have been purchases and 71 have been sales.

Here’s a breakdown of recent trading of $AMZN stock by insiders over the last 6 months:

• JEFFREY P BEZOS (Executive Chair) has made 0 purchases and 20 sales selling 21,900,000 shares for an estimated $4,967,871,732.
• DOUGLAS J HERRINGTON (CEO Worldwide Amazon Stores) has made 0 purchases and 22 sales selling 60,238 shares for an estimated $14,134,982.
• DAVID ZAPOLSKY (Senior Vice President) has made 0 purchases and 9 sales selling 41,340 shares for an estimated $9,155,263.
• ANDREW R JASSY (President and CEO) has made 0 purchases and 7 sales selling 39,744 shares for an estimated $8,714,211.
• MATTHEW S GARMAN (CEO Amazon Web Services) has made 0 purchases and 7 sales selling 35,553 shares for an estimated $7,794,622.
• BRIAN T OLSAVSKY (Senior Vice President and CFO) sold 17,750 shares for an estimated $3,953,635
• JONATHAN RUBINSTEIN sold 8,173 shares for an estimated $2,043,495
• SHELLEY REYNOLDS (Vice President) has made 0 purchases and 2 sales selling 2,715 shares for an estimated $601,754.
• DANIEL P HUTTENLOCHER sold 1,237 shares for an estimated $280,316
• KEITH BRIAN ALEXANDER sold 900 shares for an estimated $209,700

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Amazon Revenue

Amazon had revenues of $180.2B in Q3 2025. This is an increase of 13.4% from the same period in the prior year.

You can track AMZN financials on Quiver Quantitative's AMZN stock page.

Amazon Congressional Stock Trading

Members of Congress have traded $AMZN stock 25 times in the past 6 months. Of those trades, 20 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $AMZN stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 3 purchases worth up to $80,000 on 11/18, 10/17 and 0 sales.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 11/13.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 10/24, 10/15, 10/09 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 5 times. They made 1 purchase worth up to $15,000 on 09/11 and 4 sales worth up to $60,000 on 10/14, 09/25, 08/04, 07/22.
• REPRESENTATIVE VAL T. HOYLE has traded it 3 times. They made 2 purchases worth up to $30,000 on 09/10, 07/02 and 1 sale worth up to $50,000 on 09/23.
• REPRESENTATIVE CLEO FIELDS has traded it 10 times. They made 10 purchases worth up to $1,565,000 on 09/17, 09/10, 09/03, 08/15, 08/01, 07/29, 07/16, 07/14, 06/30 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Amazon Hedge Fund Activity

We have seen 2,940 institutional investors add shares of Amazon stock to their portfolio, and 2,289 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 132,610,792 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $29,117,351,599
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 60,576,391 shares (+77.7%) to their portfolio in Q3 2025, for an estimated $13,300,758,171
• PRICE T ROWE ASSOCIATES INC /MD/ removed 15,198,274 shares (-9.6%) from their portfolio in Q3 2025, for an estimated $3,337,085,022
• FMR LLC removed 15,193,151 shares (-4.4%) from their portfolio in Q3 2025, for an estimated $3,335,960,165
• JPMORGAN CHASE & CO removed 10,138,990 shares (-5.3%) from their portfolio in Q3 2025, for an estimated $2,226,218,034
• CAPITAL RESEARCH GLOBAL INVESTORS added 9,583,217 shares (+11.3%) to their portfolio in Q3 2025, for an estimated $2,104,186,956
• BLACKROCK, INC. added 9,522,155 shares (+1.3%) to their portfolio in Q3 2025, for an estimated $2,090,779,573

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Amazon Analyst Ratings

Wall Street analysts have issued reports on $AMZN in the last several months. We have seen 31 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• TD Cowen issued a "Buy" rating on 12/11/2025
• Guggenheim issued a "Buy" rating on 12/10/2025
• Oppenheimer issued a "Outperform" rating on 12/01/2025
• Rosenblatt issued a "Buy" rating on 11/25/2025
• Mizuho issued a "Outperform" rating on 11/04/2025
• Bernstein issued a "Outperform" rating on 10/31/2025
• UBS issued a "Buy" rating on 10/31/2025

To track analyst ratings and price targets for Amazon, check out Quiver Quantitative's $AMZN forecast page.

Amazon Price Targets

Multiple analysts have issued price targets for $AMZN recently. We have seen 36 analysts offer price targets for $AMZN in the last 6 months, with a median target of $300.0.

Here are some recent targets:

• Brian Pitz from BMO Capital set a target price of $304.0 on 12/16/2025
• John Blackledge from TD Cowen set a target price of $300.0 on 12/11/2025
• Simeon Siegel from Guggenheim set a target price of $300.0 on 12/10/2025
• Barton Crockett from Rosenblatt set a target price of $305.0 on 12/04/2025
• Justin Post from B of A Securities set a target price of $303.0 on 12/03/2025
• Andrew Boone from Citizens set a target price of $300.0 on 12/03/2025
• Scott Devitt from Wedbush set a target price of $340.0 on 12/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

AI Deal Sparks Buzz: Recent discussions on social media about NVIDIA have centered on a major $20 billion deal with AI startup Groq. Many users are highlighting this as a bold move to solidify dominance in the AI chip market. The conversation also notes positive momentum from reports of H200 chip exports to China being cleared.

Market Optimism: There’s a strong focus on NVIDIA’s upcoming Blackwell and Rubin architectures, with some users citing massive bookings and accelerating demand. A few voices express concern over potential regulatory hurdles, but the overall tone leans toward confidence in the company’s growth. Analysts’ price targets shared in the discussions further fuel optimism about future gains.

Note: This discussion summary was generated from an AI condensation of post data.

NVIDIA Insider Trading Activity

NVIDIA insiders have traded $NVDA stock on the open market 511 times in the past 6 months. Of those trades, 0 have been purchases and 511 have been sales.

Here’s a breakdown of recent trading of $NVDA stock by insiders over the last 6 months:

• JEN HSUN HUANG (President and CEO) has made 0 purchases and 354 sales selling 5,625,000 shares for an estimated $991,941,033.
• MARK A STEVENS has made 0 purchases and 5 sales selling 1,420,297 shares for an estimated $253,987,187.
• HARVEY C JONES has made 0 purchases and 2 sales selling 500,000 shares for an estimated $88,387,150.
• A BROOKE SEAWELL has made 0 purchases and 34 sales selling 462,611 shares for an estimated $74,340,458.
• DEBORA SHOQUIST (EVP, Operations) has made 0 purchases and 20 sales selling 309,840 shares for an estimated $56,186,171.
• COLETTE KRESS (EVP & Chief Financial Officer) has made 0 purchases and 84 sales selling 291,570 shares for an estimated $53,095,710.
• DAWN E HUDSON has made 0 purchases and 2 sales selling 90,000 shares for an estimated $15,381,064.
• PERSIS DRELL sold 40,000 shares for an estimated $7,106,120
• DONALD F JR ROBERTSON (Principal Accounting Officer) has made 0 purchases and 7 sales selling 28,090 shares for an estimated $5,043,024.
• STEPHEN C NEAL sold 28,000 shares for an estimated $4,972,343
• JOHN DABIRI sold 626 shares for an estimated $112,316

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NVIDIA Revenue

NVIDIA had revenues of $57B in Q3 2026. This is an increase of 62.49% from the same period in the prior year.

You can track NVDA financials on Quiver Quantitative's NVDA stock page.

NVIDIA Congressional Stock Trading

Members of Congress have traded $NVDA stock 46 times in the past 6 months. Of those trades, 40 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $NVDA stock by members of Congress over the last 6 months:

• REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 11/21.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $65,000 on 11/18, 10/17 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $50,000 on 10/30 and 2 sales worth up to $100,000 on 10/31, 10/30.
• REPRESENTATIVE CLEO FIELDS has traded it 34 times. They made 34 purchases worth up to $6,000,000 on 10/30, 09/03, 08/22, 08/20, 08/15, 08/13, 08/06, 08/01, 07/29, 07/17, 07/16, 07/14, 07/10, 06/30 and 0 sales.
• SENATOR SHELDON WHITEHOUSE has traded it 3 times. They made 0 purchases and 3 sales worth up to $150,000 on 10/20, 09/04, 07/07.
• REPRESENTATIVE VAL T. HOYLE sold up to $100,000 on 09/23.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 08/22.
• SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

NVIDIA Hedge Fund Activity

We have seen 2,608 institutional investors add shares of NVIDIA stock to their portfolio, and 2,493 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 382,240,291 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $71,318,393,494
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 155,215,336 shares (+65.3%) to their portfolio in Q3 2025, for an estimated $28,960,077,390
• CLEAR STREET LLC added 28,275,055 shares (+470.5%) to their portfolio in Q2 2025, for an estimated $4,467,175,939
• JPMORGAN CHASE & CO added 26,032,415 shares (+5.6%) to their portfolio in Q3 2025, for an estimated $4,857,127,990
• CLEAR STREET DERIVATIVES LLC removed 25,689,318 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,058,655,350
• CAPITAL RESEARCH GLOBAL INVESTORS added 22,896,705 shares (+16.1%) to their portfolio in Q3 2025, for an estimated $4,272,067,218
• BLACKROCK, INC. added 19,470,172 shares (+1.0%) to their portfolio in Q3 2025, for an estimated $3,632,744,691

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NVIDIA Analyst Ratings

Wall Street analysts have issued reports on $NVDA in the last several months. We have seen 31 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Bernstein issued a "Outperform" rating on 12/26/2025
• B of A Securities issued a "Buy" rating on 12/26/2025
• Baird issued a "Outperform" rating on 12/26/2025
• Tigress Financial issued a "Strong Buy" rating on 12/18/2025
• Morgan Stanley issued a "Overweight" rating on 12/01/2025
• JP Morgan issued a "Overweight" rating on 11/20/2025
• Keybanc issued a "Overweight" rating on 11/20/2025

To track analyst ratings and price targets for NVIDIA, check out Quiver Quantitative's $NVDA forecast page.

NVIDIA Price Targets

Multiple analysts have issued price targets for $NVDA recently. We have seen 35 analysts offer price targets for $NVDA in the last 6 months, with a median target of $250.0.

Here are some recent targets:

• Stacy Rasgon from Bernstein set a target price of $275.0 on 12/26/2025
• Tristan Gerra from Baird set a target price of $275.0 on 12/26/2025
• Vivek Arya from B of A Securities set a target price of $275.0 on 12/26/2025
• William Stein from Truist Securities set a target price of $275.0 on 12/19/2025
• Ivan Feinseth from Tigress Financial set a target price of $350.0 on 12/18/2025
• Joseph Moore from Morgan Stanley set a target price of $250.0 on 12/01/2025
• Harlan Sur from JP Morgan set a target price of $250.0 on 11/20/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Audit Reforms in Focus: Recent chatter on social media about UnitedHealth Group has zeroed in on the company’s 23-point action plan following an independent audit. Many are debating if these changes will restore trust after patient backlash and scrutiny. There’s cautious optimism around the push for transparency and automation.

Stock Performance Concerns: Discussions also highlight the stock’s rough year, with significant declines making it a standout underperformer in major indices. Some voices on social media suggest a potential rebound if management tackles costs and regulatory hurdles. The mix of fear and hope keeps the conversation lively.

Regulatory Headwinds: Regulatory pressures and political rhetoric around health insurance profits are stoking uncertainty among commenters. Posts often mention fears of policy changes impacting revenue, though a few argue the company’s size offers resilience. It’s a tense topic with no clear consensus.

Note: This discussion summary was generated from an AI condensation of post data.

UnitedHealth Group Insider Trading Activity

UnitedHealth Group insiders have traded $UNH stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $UNH stock by insiders over the last 6 months:

• CHARLES D. BAKER sold 27 shares for an estimated $9,613

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UnitedHealth Group Revenue

UnitedHealth Group had revenues of $113.2B in Q3 2025. This is an increase of 12.24% from the same period in the prior year.

You can track UNH financials on Quiver Quantitative's UNH stock page.

UnitedHealth Group Congressional Stock Trading

Members of Congress have traded $UNH stock 26 times in the past 6 months. Of those trades, 12 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 11/13, 08/14, 07/24.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $30,000 on 10/09, 09/05 and 2 sales worth up to $65,000 on 11/12, 08/05.
• REPRESENTATIVE RICHARD MCCORMICK has traded it 2 times. They made 1 purchase worth up to $15,000 on 11/05 and 1 sale worth up to $15,000 on 09/18.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 10/30, 08/13 and 2 sales worth up to $30,000 on 10/31, 10/30.
• SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 1 purchase worth up to $50,000 on 09/24 and 1 sale worth up to $50,000 on 08/01.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
• SENATOR SHELDON WHITEHOUSE has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 09/04, 08/28.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 08/28, 08/04 and 0 sales.
• REPRESENTATIVE TIM MOORE has traded it 5 times. They made 4 purchases worth up to $130,000 on 08/08, 08/01, 07/21, 07/16 and 1 sale worth up to $100,000 on 08/15.
• SENATOR ANGUS S. KING JR. sold up to $15,000 on 07/15.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

UnitedHealth Group Hedge Fund Activity

We have seen 1,592 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 2,138 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP removed 7,697,387 shares (-31.8%) from their portfolio in Q3 2025, for an estimated $2,657,907,731
• CAPITAL RESEARCH GLOBAL INVESTORS added 7,293,009 shares (+126.9%) to their portfolio in Q3 2025, for an estimated $2,518,276,007
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 5,146,915 shares (+59.8%) to their portfolio in Q3 2025, for an estimated $1,777,229,749
• PRICE T ROWE ASSOCIATES INC /MD/ removed 3,768,686 shares (-17.2%) from their portfolio in Q3 2025, for an estimated $1,301,327,275
• CAPITAL WORLD INVESTORS added 3,439,182 shares (+18.8%) to their portfolio in Q3 2025, for an estimated $1,187,549,544
• FMR LLC removed 3,112,368 shares (-18.5%) from their portfolio in Q3 2025, for an estimated $1,074,700,670
• APPALOOSA LP removed 2,246,500 shares (-91.7%) from their portfolio in Q3 2025, for an estimated $775,716,450

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UnitedHealth Group Government Contracts

We have seen $14,334,586,429 of award payments to $UNH over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• EXPRESS REPORT: R3 FY25 3RD QTR APRIL: $830,362,703
• EXPRESS REPORT: R3 FY25 3RD QTR MAY: $819,320,444
• EXPRESS REPORT: R3 FY25 2ND QTR MARCH: $791,841,212
• EXPRESS REPORT: R3 FY25 2ND QTR JANUARY: $732,700,373
• EXPRESS REPORT: R3 FY25 2ND QTR FEBRUARY: $730,504,137

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

UnitedHealth Group Analyst Ratings

Wall Street analysts have issued reports on $UNH in the last several months. We have seen 14 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Bernstein issued a "Outperform" rating on 10/30/2025
• Piper Sandler issued a "Overweight" rating on 10/29/2025
• RBC Capital issued a "Outperform" rating on 10/29/2025
• UBS issued a "Buy" rating on 10/29/2025
• Jefferies issued a "Buy" rating on 10/17/2025
• Goldman Sachs issued a "Buy" rating on 10/14/2025
• Keybanc issued a "Overweight" rating on 10/08/2025

To track analyst ratings and price targets for UnitedHealth Group, check out Quiver Quantitative's $UNH forecast page.

UnitedHealth Group Price Targets

Multiple analysts have issued price targets for $UNH recently. We have seen 18 analysts offer price targets for $UNH in the last 6 months, with a median target of $403.0.

Here are some recent targets:

• Lance Wilkes from Bernstein set a target price of $440.0 on 10/30/2025
• Ryan Langston from TD Cowen set a target price of $338.0 on 10/30/2025
• Ben Hendrix from RBC Capital set a target price of $408.0 on 10/29/2025
• Jessica Tassan from Piper Sandler set a target price of $417.0 on 10/29/2025
• Kevin Caliendo from UBS set a target price of $430.0 on 10/29/2025
• David Windley from Jefferies set a target price of $409.0 on 10/17/2025
• Scott Fidel from Goldman Sachs set a target price of $406.0 on 10/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent Price Movements: GameStop stock has been a hot topic on social media lately, with discussions centering on its recent price fluctuations. Many users are speculating on the potential for significant upward movement in 2025, with some predicting dramatic price targets. The chatter reflects a high level of enthusiasm among certain investor communities.

Strategic Speculation: Beyond price predictions, there’s growing buzz around GameStop’s strategic direction, including cost reductions and potential new initiatives. Some on social media are optimistic about insider buying and the company’s cash reserves, seeing these as signs of strength. However, skepticism persists, with others questioning whether these moves will translate into long-term stability.

Note: This discussion summary was generated from an AI condensation of post data.

GameStop Insider Trading Activity

GameStop insiders have traded $GME stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $GME stock by insiders over the last 6 months:

• MARK HAYMOND ROBINSON (General Counsel and Secretary) has made 0 purchases and 4 sales selling 16,803 shares for an estimated $421,137.
• DANIEL WILLIAM MOORE (PFO and PAO) has made 0 purchases and 3 sales selling 8,060 shares for an estimated $215,626.
• JAMES GRUBE purchased 5,575 shares for an estimated $132,183

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GameStop Revenue

GameStop had revenues of $821M in Q3 2025. This is a decrease of -4.57% from the same period in the prior year.

You can track GME financials on Quiver Quantitative's GME stock page.

GameStop Hedge Fund Activity

We have seen 169 institutional investors add shares of GameStop stock to their portfolio, and 181 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CITADEL ADVISORS LLC removed 4,820,819 shares (-97.5%) from their portfolio in Q3 2025, for an estimated $131,511,942
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 3,512,016 shares (+73.7%) to their portfolio in Q3 2025, for an estimated $95,807,796
• NORGES BANK added 3,080,586 shares (+4799.3%) to their portfolio in Q2 2025, for an estimated $75,135,492
• JANE STREET GROUP, LLC added 3,025,789 shares (+305.0%) to their portfolio in Q3 2025, for an estimated $82,543,523
• CLEAR STREET LLC added 2,354,779 shares (+inf%) to their portfolio in Q2 2025, for an estimated $57,433,059
• UBS GROUP AG removed 2,326,213 shares (-50.1%) from their portfolio in Q3 2025, for an estimated $63,459,090
• ALYESKA INVESTMENT GROUP, L.P. removed 2,128,821 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $58,074,236

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

AI Demand Surge: Recent chatter on social media highlights Taiwan Semiconductor Manufacturing Company’s strong position in the AI and semiconductor space. Many users are buzzing about the company’s impressive revenue growth, driven by high demand for AI chips. Reports of a significant year-over-year sales jump have fueled excitement among followers.

Geopolitical Concerns: Alongside the optimism, some discussions focus on potential risks tied to geopolitical tensions affecting the company’s operations. A few voices on social media suggest that these risks might be impacting the stock’s perception, with debates on whether the current price reflects true value. The mix of enthusiasm and caution keeps the conversation dynamic.

Note: This discussion summary was generated from an AI condensation of post data.

Taiwan Semiconductor Manufacturing Company Congressional Stock Trading

Members of Congress have traded $TSM stock 17 times in the past 6 months. Of those trades, 12 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $TSM stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 5 times. They made 1 purchase worth up to $15,000 on 10/30 and 4 sales worth up to $145,000 on 10/31, 10/30, 10/14, 08/28.
• REPRESENTATIVE CLEO FIELDS has traded it 8 times. They made 8 purchases worth up to $1,380,000 on 10/23, 08/15, 08/13, 08/01, 07/17 and 0 sales.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 2 purchases worth up to $30,000 on 10/10 and 0 sales.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Taiwan Semiconductor Manufacturing Company Hedge Fund Activity

We have seen 1,504 institutional investors add shares of Taiwan Semiconductor Manufacturing Company stock to their portfolio, and 1,129 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC added 11,786,038 shares (+19.2%) to their portfolio in Q3 2025, for an estimated $3,291,722,553
• SANDERS CAPITAL, LLC removed 5,999,140 shares (-15.7%) from their portfolio in Q3 2025, for an estimated $1,675,499,810
• CAPITAL WORLD INVESTORS removed 4,144,254 shares (-13.0%) from their portfolio in Q3 2025, for an estimated $1,157,448,699
• JPMORGAN CHASE & CO removed 3,887,653 shares (-13.7%) from their portfolio in Q3 2025, for an estimated $1,085,782,606
• BANK OF NEW YORK MELLON CORP removed 3,151,640 shares (-18.5%) from their portfolio in Q3 2025, for an estimated $880,221,535
• HSBC HOLDINGS PLC removed 2,797,089 shares (-67.0%) from their portfolio in Q3 2025, for an estimated $781,198,986
• BLACKROCK, INC. added 2,739,259 shares (+19.0%) to their portfolio in Q3 2025, for an estimated $765,047,646

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Taiwan Semiconductor Manufacturing Company Analyst Ratings

Wall Street analysts have issued reports on $TSM in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 10/17/2025
• Needham issued a "Buy" rating on 10/16/2025
• Susquehanna issued a "Positive" rating on 10/10/2025

To track analyst ratings and price targets for Taiwan Semiconductor Manufacturing Company, check out Quiver Quantitative's $TSM forecast page.

Taiwan Semiconductor Manufacturing Company Price Targets

Multiple analysts have issued price targets for $TSM recently. We have seen 4 analysts offer price targets for $TSM in the last 6 months, with a median target of $357.5.

Here are some recent targets:

• Mark Li from Bernstein set a target price of $330.0 on 12/08/2025
• Charles Shi from Needham set a target price of $360.0 on 10/27/2025
• Simon Coles from Barclays set a target price of $355.0 on 10/17/2025
• Mehdi Hosseini from Susquehanna set a target price of $400.0 on 10/10/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

AI Licensing Buzz: Recent chatter on social media has centered around Reddit's potential in AI data licensing, with many highlighting its unique position as a source of authentic human conversation for training models. Some users are excited about reported talks with major tech players, seeing this as a high-margin revenue stream. There’s also optimism about future deals that could further boost the company’s financials.

Analyst Optimism: Posts on social media also reflect positive analyst sentiment, with some noting Reddit being named a top pick for 2026 by investment firms. Discussions point to strong revenue growth forecasts and the stock’s appeal as both an ad platform and AI infrastructure play. However, a few voices express concern over recent dips in stock price, linking it to fluctuating AI-related traffic data.

Market Volatility: There’s a mix of reactions to Reddit’s stock performance on social media, with some pointing out significant gains over the past year while others highlight short-term declines. The dramatic swings in price, coupled with insider sales, have sparked debates about long-term stability. Overall, the conversation remains lively as investors weigh the company’s innovative edge against market risks.

Note: This discussion summary was generated from an AI condensation of post data.

Reddit Insider Trading Activity

Reddit insiders have traded $RDDT stock on the open market 365 times in the past 6 months. Of those trades, 0 have been purchases and 365 have been sales.

Here’s a breakdown of recent trading of $RDDT stock by insiders over the last 6 months:

• JENNIFER L. WONG (Chief Operating Officer) has made 0 purchases and 99 sales selling 359,381 shares for an estimated $75,615,867.
• STEVE LADD HUFFMAN (CEO & President) has made 0 purchases and 109 sales selling 200,000 shares for an estimated $41,653,865.
• CHRISTOPHER BRIAN SLOWE (Chief Technology Officer) has made 0 purchases and 95 sales selling 162,000 shares for an estimated $33,909,009.
• BENJAMIN SEONG LEE (Chief Legal Officer) has made 0 purchases and 29 sales selling 86,608 shares for an estimated $19,321,435.
• ANDREW VOLLERO (Chief Financial Officer) has made 0 purchases and 8 sales selling 30,000 shares for an estimated $6,542,556.
• MICHELLE MARIE REYNOLDS (Chief Accounting Officer) has made 0 purchases and 25 sales selling 21,178 shares for an estimated $4,628,597.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Reddit Revenue

Reddit had revenues of $584.9M in Q3 2025. This is an increase of 67.91% from the same period in the prior year.

You can track RDDT financials on Quiver Quantitative's RDDT stock page.

Reddit Hedge Fund Activity

We have seen 524 institutional investors add shares of Reddit stock to their portfolio, and 362 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO added 2,807,862 shares (+136.9%) to their portfolio in Q3 2025, for an estimated $645,780,181
• CRESSET ASSET MANAGEMENT, LLC added 2,450,793 shares (+196.4%) to their portfolio in Q3 2025, for an estimated $563,657,882
• FMR LLC added 2,308,733 shares (+20.6%) to their portfolio in Q3 2025, for an estimated $530,985,502
• QUANTINNO CAPITAL MANAGEMENT LP added 2,011,418 shares (+110214.7%) to their portfolio in Q3 2025, for an estimated $462,606,025
• SCGE MANAGEMENT, L.P. removed 1,612,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $242,718,840
• NORGES BANK added 1,513,635 shares (+343.5%) to their portfolio in Q2 2025, for an estimated $227,908,021
• TIGER GLOBAL MANAGEMENT LLC removed 1,476,469 shares (-24.0%) from their portfolio in Q3 2025, for an estimated $339,573,105

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Reddit Analyst Ratings

Wall Street analysts have issued reports on $RDDT in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 12/23/2025
• Citigroup issued a "Buy" rating on 11/03/2025
• B. Riley Securities issued a "Buy" rating on 10/31/2025
• Piper Sandler issued a "Overweight" rating on 09/18/2025
• JMP Securities issued a "Market Outperform" rating on 09/18/2025
• Oppenheimer issued a "Outperform" rating on 09/16/2025
• Jefferies issued a "Buy" rating on 09/10/2025

To track analyst ratings and price targets for Reddit, check out Quiver Quantitative's $RDDT forecast page.

Reddit Price Targets

Multiple analysts have issued price targets for $RDDT recently. We have seen 18 analysts offer price targets for $RDDT in the last 6 months, with a median target of $242.5.

Here are some recent targets:

• Laura Martin from Needham set a target price of $300.0 on 12/23/2025
• John Colantuoni from Jefferies set a target price of $325.0 on 12/11/2025
• Ronald Josey from Citigroup set a target price of $265.0 on 11/03/2025
• Mark Shmulik from Bernstein set a target price of $210.0 on 10/31/2025
• Doug Anmuth from JP Morgan set a target price of $227.0 on 10/31/2025
• Justin Post from B of A Securities set a target price of $210.0 on 10/31/2025
• Naved Khan from B. Riley Securities set a target price of $245.0 on 10/31/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Cannabis Policy Shift: Recent discussions on social media about Tilray Brands have centered on the potential rescheduling of cannabis in the U.S. Many users are excited about the company’s strategic moves into the U.S. medical cannabis market. The buzz reflects hope for significant growth as regulatory barriers may ease.

Stock Performance Surge: Conversations also highlight Tilray’s impressive stock rally, with some noting a near tripling in value over recent months. There’s debate over whether the current price reflects true potential or speculative hype. Investors appear divided on the sustainability of this upward trend.

Note: This discussion summary was generated from an AI condensation of post data.

Tilray Brands Insider Trading Activity

Tilray Brands insiders have traded $TLRY stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $TLRY stock by insiders over the last 6 months:

• IRWIN D SIMON (President and CEO) purchased 165,000 shares for an estimated $100,105
• CARL A MERTON (Chief Financial Officer) purchased 33,500 shares for an estimated $19,939
• MITCHELL GENDEL (Global General Counsel) purchased 6,000 shares for an estimated $3,496

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Tilray Brands Revenue

Tilray Brands had revenues of $209.5M in Q1 2026. This is an increase of 4.73% from the same period in the prior year.

You can track TLRY financials on Quiver Quantitative's TLRY stock page.

Tilray Brands Hedge Fund Activity

We have seen 144 institutional investors add shares of Tilray Brands stock to their portfolio, and 147 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• HRT FINANCIAL LP added 13,851,212 shares (+1387.8%) to their portfolio in Q3 2025, for an estimated $23,962,596
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 5,707,463 shares (+129.2%) to their portfolio in Q3 2025, for an estimated $9,873,910
• CITADEL ADVISORS LLC removed 3,705,712 shares (-66.7%) from their portfolio in Q3 2025, for an estimated $6,410,881
• MILLENNIUM MANAGEMENT LLC added 3,645,060 shares (+281.0%) to their portfolio in Q3 2025, for an estimated $6,305,953
• MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 3,360,016 shares (+inf%) to their portfolio in Q3 2025, for an estimated $5,812,827
• TIDAL INVESTMENTS LLC removed 2,841,305 shares (-9.8%) from their portfolio in Q3 2025, for an estimated $4,915,457
• ARISTEIA CAPITAL, L.L.C. removed 2,436,913 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,009,856

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Stablecoin Launch Buzz: Recent discussions on social media have been dominated by SoFi Technologies, Inc.'s launch of its new stablecoin, SoFiUSD. Many are excited about this move, seeing it as a bold step into blockchain and fintech innovation. There’s a sense that this could position the company as a market leader.

Growth and Challenges: Alongside the stablecoin news, conversations also focus on SoFi’s strong revenue growth, with some highlighting year-over-year increases as proof of its tech-driven edge. However, concerns about intensified competition from traditional banks and other fintechs are also surfacing. A few voices question whether current growth rates can sustain the stock’s high valuation.

Note: This discussion summary was generated from an AI condensation of post data.

SoFi Technologies, Inc. Insider Trading Activity

SoFi Technologies, Inc. insiders have traded $SOFI stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $SOFI stock by insiders over the last 6 months:

• JEREMY RISHEL (Chief Technology Officer) has made 0 purchases and 2 sales selling 190,570 shares for an estimated $5,161,695.
• KELLI KEOUGH (EVP, GBUL, SIPS) has made 0 purchases and 6 sales selling 60,725 shares for an estimated $1,551,954.
• ARUN PINTO (Chief Risk Officer) sold 46,132 shares for an estimated $1,142,219

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SoFi Technologies, Inc. Revenue

SoFi Technologies, Inc. had revenues of $961.6M in Q3 2025. This is an increase of 37.94% from the same period in the prior year.

You can track SOFI financials on Quiver Quantitative's SOFI stock page.

SoFi Technologies, Inc. Hedge Fund Activity

We have seen 540 institutional investors add shares of SoFi Technologies, Inc. stock to their portfolio, and 365 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO added 42,021,002 shares (+881.1%) to their portfolio in Q3 2025, for an estimated $1,110,194,872
• BLACKROCK, INC. added 13,553,691 shares (+27.8%) to their portfolio in Q3 2025, for an estimated $358,088,516
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 7,904,894 shares (+278.5%) to their portfolio in Q3 2025, for an estimated $208,847,299
• JANE STREET GROUP, LLC added 6,925,814 shares (+61.0%) to their portfolio in Q3 2025, for an estimated $182,980,005
• VANGUARD GROUP INC added 6,814,727 shares (+6.8%) to their portfolio in Q3 2025, for an estimated $180,045,087
• MARSHALL WACE, LLP removed 6,590,693 shares (-82.4%) from their portfolio in Q3 2025, for an estimated $174,126,109
• VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 6,482,683 shares (-39.3%) from their portfolio in Q3 2025, for an estimated $171,272,484

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SoFi Technologies, Inc. Analyst Ratings

Wall Street analysts have issued reports on $SOFI in the last several months. We have seen 3 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 10/29/2025
• Citigroup issued a "Buy" rating on 10/29/2025
• Keefe, Bruyette & Woods issued a "Underperform" rating on 10/29/2025
• Mizuho issued a "Outperform" rating on 09/18/2025
• Morgan Stanley issued a "Underweight" rating on 07/30/2025

To track analyst ratings and price targets for SoFi Technologies, Inc., check out Quiver Quantitative's $SOFI forecast page.

SoFi Technologies, Inc. Price Targets

Multiple analysts have issued price targets for $SOFI recently. We have seen 13 analysts offer price targets for $SOFI in the last 6 months, with a median target of $27.5.

Here are some recent targets:

• Matthew Coad from Truist Securities set a target price of $28.0 on 11/25/2025
• Tim Chiodo from UBS set a target price of $27.5 on 10/30/2025
• Kyle Peterson from Needham set a target price of $36.0 on 10/29/2025
• Michael Ng from Goldman Sachs set a target price of $27.0 on 10/29/2025
• Timothy Switzer from Keefe, Bruyette & Woods set a target price of $20.0 on 10/29/2025
• Peter Christiansen from Citigroup set a target price of $37.0 on 10/29/2025
• Reginald Smith from JP Morgan set a target price of $28.0 on 10/29/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Google Cloud Partnership: Recent buzz on social media has centered around Palo Alto Networks’ expanded partnership with Google Cloud, announced in late December 2025. Many users are discussing how this multi-billion-dollar deal could position the company as a leader in AI-driven cybersecurity. The focus is on the integration of security platforms and its potential to boost growth.

Cybersecurity Trends: Conversations also highlight the company’s strategic moves, including potential acquisitions and its shift toward a platform-based security model. There’s notable excitement about how these developments might strengthen its market position in 2026. Some have raised concerns over vulnerabilities in products like GlobalProtect, though, keeping the dialogue dynamic.

Note: This discussion summary was generated from an AI condensation of post data.

Palo Alto Networks Insider Trading Activity

Palo Alto Networks insiders have traded $PANW stock on the open market 69 times in the past 6 months. Of those trades, 0 have been purchases and 69 have been sales.

Here’s a breakdown of recent trading of $PANW stock by insiders over the last 6 months:

• NIKESH ARORA (Chief Executive Officer) has made 0 purchases and 7 sales selling 846,408 shares for an estimated $172,721,695.
• LEE KLARICH (EVP Chief Product & Tech Ofcr) has made 0 purchases and 31 sales selling 724,644 shares for an estimated $143,155,898.
• NIR ZUK (EVP, Chief Technology Officer) has made 0 purchases and 17 sales selling 200,000 shares for an estimated $37,146,511.
• JAMES J GOETZ has made 0 purchases and 5 sales selling 25,000 shares for an estimated $4,880,042.
• DIPAK GOLECHHA (EVP, Chief Financial Officer) has made 0 purchases and 5 sales selling 5,000 shares for an estimated $1,020,942.
• JOSH D. PAUL (Chief Accounting Officer) has made 0 purchases and 4 sales selling 2,700 shares for an estimated $537,892.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Palo Alto Networks Revenue

Palo Alto Networks had revenues of $2.5B in Q1 2026. This is an increase of 15.66% from the same period in the prior year.

You can track PANW financials on Quiver Quantitative's PANW stock page.

Palo Alto Networks Congressional Stock Trading

Members of Congress have traded $PANW stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $PANW stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.
• SENATOR JOHN W. HICKENLOOPER purchased up to $250,000 on 09/02.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 08/19.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/10 and 1 sale worth up to $15,000 on 07/16.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Palo Alto Networks Hedge Fund Activity

We have seen 1,475 institutional investors add shares of Palo Alto Networks stock to their portfolio, and 869 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 4,423,091 shares (+59.6%) to their portfolio in Q3 2025, for an estimated $900,629,789
• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 3,092,454 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $629,685,483
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 2,882,007 shares (+568.5%) to their portfolio in Q3 2025, for an estimated $586,834,265
• FMR LLC removed 2,772,474 shares (-26.7%) from their portfolio in Q3 2025, for an estimated $564,531,155
• JANE STREET GROUP, LLC added 2,608,526 shares (+169384.8%) to their portfolio in Q3 2025, for an estimated $531,148,064
• ROYAL BANK OF CANADA added 2,454,869 shares (+32.9%) to their portfolio in Q3 2025, for an estimated $499,860,425
• CITADEL ADVISORS LLC added 2,271,937 shares (+882.5%) to their portfolio in Q3 2025, for an estimated $462,611,811

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Palo Alto Networks Analyst Ratings

Wall Street analysts have issued reports on $PANW in the last several months. We have seen 25 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 12/18/2025
• JP Morgan issued a "Overweight" rating on 12/17/2025
• HSBC issued a "Reduce" rating on 11/21/2025
• Goldman Sachs issued a "Buy" rating on 11/21/2025
• Rosenblatt issued a "Buy" rating on 11/20/2025
• Needham issued a "Buy" rating on 11/20/2025
• Bernstein issued a "Outperform" rating on 11/20/2025

To track analyst ratings and price targets for Palo Alto Networks, check out Quiver Quantitative's $PANW forecast page.

Palo Alto Networks Price Targets

Multiple analysts have issued price targets for $PANW recently. We have seen 29 analysts offer price targets for $PANW in the last 6 months, with a median target of $230.0.

Here are some recent targets:

• Hamza Fodderwala from Morgan Stanley set a target price of $245.0 on 12/18/2025
• Brian Essex from JP Morgan set a target price of $235.0 on 12/17/2025
• Stephen Bersey from HSBC set a target price of $157.0 on 11/21/2025
• Gabriela Borges from Goldman Sachs set a target price of $240.0 on 11/21/2025
• Roger Boyd from UBS set a target price of $220.0 on 11/20/2025
• Jonathan Ruykhaver from Cantor Fitzgerald set a target price of $250.0 on 11/20/2025
• Daniel Ives from Wedbush set a target price of $225.0 on 11/20/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Analyst Upgrade Buzz: Recent chatter on social media about Recursion Pharmaceuticals has been ignited by a notable upgrade from a major financial institution. Many are highlighting a raised price target and expressing optimism around the company’s lead drug candidate. The discussion reflects a renewed interest in the stock’s trajectory.

Clinical Data Hype: Another focal point online is the encouraging data from the TUPELO trial, sparking excitement among followers of the company. Some express hope that this could be a turning point for the stock after a challenging period. There’s also buzz around the firm’s AI-driven drug discovery approach as a unique edge.

Note: This discussion summary was generated from an AI condensation of post data.

Recursion Pharmaceuticals Insider Trading Activity

Recursion Pharmaceuticals insiders have traded $RXRX stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $RXRX stock by insiders over the last 6 months:

• CHRISTOPHER GIBSON (Chief Executive Officer) has made 0 purchases and 12 sales selling 1,278,175 shares for an estimated $6,608,964.
• BLAKE BORGESON sold 220,000 shares for an estimated $961,400
• NAJAT KHAN (Chief R&D Commercial Officer) sold 36,599 shares for an estimated $202,172

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had revenues of $5.2M in Q3 2025. This is a decrease of -80.16% from the same period in the prior year.

You can track RXRX financials on Quiver Quantitative's RXRX stock page.

Recursion Pharmaceuticals Hedge Fund Activity

We have seen 178 institutional investors add shares of Recursion Pharmaceuticals stock to their portfolio, and 175 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• STATE STREET CORP added 7,089,386 shares (+63.4%) to their portfolio in Q3 2025, for an estimated $34,596,203
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,778,440 shares (+81.9%) to their portfolio in Q3 2025, for an estimated $18,438,787
• VANGUARD GROUP INC added 3,708,975 shares (+10.3%) to their portfolio in Q3 2025, for an estimated $18,099,798
• BLACKROCK, INC. added 3,368,702 shares (+11.9%) to their portfolio in Q3 2025, for an estimated $16,439,265
• FMR LLC removed 2,356,001 shares (-42.2%) from their portfolio in Q3 2025, for an estimated $11,497,284
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 2,183,837 shares (+68.1%) to their portfolio in Q3 2025, for an estimated $10,657,124
• GEODE CAPITAL MANAGEMENT, LLC added 1,847,149 shares (+23.8%) to their portfolio in Q3 2025, for an estimated $9,014,087

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Recursion Pharmaceuticals Analyst Ratings

Wall Street analysts have issued reports on $RXRX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Overweight" rating on 12/17/2025
• Needham issued a "Buy" rating on 09/11/2025

To track analyst ratings and price targets for Recursion Pharmaceuticals, check out Quiver Quantitative's $RXRX forecast page.

Recursion Pharmaceuticals Price Targets

Multiple analysts have issued price targets for $RXRX recently. We have seen 3 analysts offer price targets for $RXRX in the last 6 months, with a median target of $8.0.

Here are some recent targets:

• Eric Joseph from JP Morgan set a target price of $11.0 on 12/17/2025
• Gil Blum from Needham set a target price of $8.0 on 09/11/2025
• Vikram Purohit from Morgan Stanley set a target price of $5.0 on 07/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

NFL Christmas Coverage Issues: Recent chatter on social media has been heavily focused on Netflix's technical glitches during its NFL Christmas Day game broadcasts. Many users expressed frustration over streaming lags and low-resolution issues, raising doubts about the company's ability to handle live sports events. This has sparked heated debates about the platform's infrastructure and readiness for such high-stakes content.

Warner Bros. Deal Uncertainty: Another hot topic circulating online is the potential acquisition of Warner Bros. Discovery by Netflix, with significant concern over the deal's uncertainty. Discussions highlight a notable drop in stock price linked to the bid, with some users speculating on the financial and strategic risks involved. The mixed opinions reflect anxiety over how this could shape the company's future trajectory.

Note: This discussion summary was generated from an AI condensation of post data.

Netflix Insider Trading Activity

Netflix insiders have traded $NFLX stock on the open market 230 times in the past 6 months. Of those trades, 0 have been purchases and 230 have been sales.

Here’s a breakdown of recent trading of $NFLX stock by insiders over the last 6 months:

• REED HASTINGS has made 0 purchases and 133 sales selling 533,257 shares for an estimated $227,910,956.
• DAVID A HYMAN (Chief Legal Officer) has made 0 purchases and 3 sales selling 31,886 shares for an estimated $35,094,467.
• SPENCER ADAM NEUMANN (Chief Financial Officer) has made 0 purchases and 87 sales selling 14,382 shares for an estimated $17,027,209.
• GREGORY K PETERS (Co-CEO) has made 0 purchases and 2 sales selling 4,053 shares for an estimated $4,565,906.
• THEODORE A SARANDOS (Co-CEO) has made 0 purchases and 2 sales selling 4,053 shares for an estimated $4,565,049.
• CLETUS R WILLEMS (Chief Global Affairs Officer) has made 0 purchases and 2 sales selling 476 shares for an estimated $536,416.
• STRIVE MASIYIWA sold 290 shares for an estimated $387,596

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Netflix Revenue

Netflix had revenues of $11.5B in Q3 2025. This is an increase of 17.16% from the same period in the prior year.

You can track NFLX financials on Quiver Quantitative's NFLX stock page.

Netflix Congressional Stock Trading

Members of Congress have traded $NFLX stock 16 times in the past 6 months. Of those trades, 12 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $NFLX stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 7 times. They made 7 purchases worth up to $1,280,000 on 12/03, 11/20, 11/03, 10/31 and 0 sales.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 1 sale worth up to $15,000 on 10/07.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
• SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Netflix Hedge Fund Activity

We have seen 1,837 institutional investors add shares of Netflix stock to their portfolio, and 1,412 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CANADA LIFE ASSURANCE CO added 4,888,411 shares (+874.4%) to their portfolio in Q3 2025, for an estimated $586,081,371
• PICTET ASSET MANAGEMENT HOLDING SA added 4,472,536 shares (+982.1%) to their portfolio in Q3 2025, for an estimated $536,221,286
• ALECTA TJANSTEPENSION OMSESIDIGT added 3,818,000 shares (+863.8%) to their portfolio in Q3 2025, for an estimated $457,747,656
• DANSKE BANK A/S removed 3,117,850 shares (-97.9%) from their portfolio in Q3 2025, for an estimated $373,805,272
• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 2,463,158 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,953,129,389
• CIBC PRIVATE WEALTH GROUP LLC added 2,081,494 shares (+914.6%) to their portfolio in Q3 2025, for an estimated $249,554,478
• GQG PARTNERS LLC removed 1,478,301 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,772,364,634

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Netflix Analyst Ratings

Wall Street analysts have issued reports on $NFLX in the last several months. We have seen 14 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 12/09/2025
• Rosenblatt issued a "Buy" rating on 11/28/2025
• KGI Securities issued a "Outperform" rating on 11/03/2025
• Wells Fargo issued a "Overweight" rating on 10/22/2025
• Wedbush issued a "Outperform" rating on 10/22/2025
• Canaccord Genuity issued a "Buy" rating on 10/22/2025
• Guggenheim issued a "Buy" rating on 10/22/2025

To track analyst ratings and price targets for Netflix, check out Quiver Quantitative's $NFLX forecast page.

Netflix Price Targets

Multiple analysts have issued price targets for $NFLX recently. We have seen 26 analysts offer price targets for $NFLX in the last 6 months, with a median target of $1390.0.

Here are some recent targets:

• James Heaney from Jefferies set a target price of $134.0 on 12/11/2025
• Laura Martin from Needham set a target price of $150.0 on 12/09/2025
• Maria Ripps from Canaccord Genuity set a target price of $152.5 on 12/08/2025
• Barton Crockett from Rosenblatt set a target price of $105.0 on 12/08/2025
• Jeffrey Wlodarczak from Pivotal Research set a target price of $105.0 on 12/08/2025
• Doug Anmuth from JP Morgan set a target price of $124.0 on 11/18/2025
• Kannan Venkateshwar from Barclays set a target price of $110.0 on 11/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

AI Concerns Dominate: Recent discussions on social media about Oracle Corporation have heavily focused on its significant stock decline, with shares dropping over 40% from a September peak. Many users express worry over the company’s aggressive AI investments, citing rising debt and delayed infrastructure projects as red flags. This has sparked debates about whether the AI hype is a bubble waiting to burst.

Mixed Perspectives Emerge: Despite the downturn, some on social media highlight Oracle’s massive cloud revenue projections and AI data center commitments as reasons for optimism. A few argue the current pessimism has left the stock undervalued, pointing to analyst price targets far above current levels. Others remain skeptical, questioning if the company’s financial strategy can sustain such ambitious growth.

Note: This discussion summary was generated from an AI condensation of post data.

Oracle Corporation Insider Trading Activity

Oracle Corporation insiders have traded $ORCL stock on the open market 19 times in the past 6 months. Of those trades, 1 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by insiders over the last 6 months:

• MICHAEL D. SICILIA (President, Industries) has made 0 purchases and 3 sales selling 66,048 shares for an estimated $20,029,695.
• CLAYTON M. MAGOUYRK (Chief Executive Officer) has made 0 purchases and 3 sales selling 71,241 shares for an estimated $19,301,524.
• JEFFREY BERG has made 0 purchases and 4 sales selling 49,365 shares for an estimated $13,971,266.
• STUART LEVEY (EVP, Chief Legal Officer) sold 19,758 shares for an estimated $5,927,400
• MARIA SMITH (EVP, Chief Accounting Officer) has made 0 purchases and 3 sales selling 20,000 shares for an estimated $5,133,019.
• WILLIAM G PARRETT sold 11,500 shares for an estimated $3,519,000
• NAOMI O SELIGMAN has made 0 purchases and 3 sales selling 7,748 shares for an estimated $1,849,678.
• RONA ALISON FAIRHEAD purchased 480 shares for an estimated $112,257

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Oracle Corporation Revenue

Oracle Corporation had revenues of $16.1B in Q2 2026. This is an increase of 14.22% from the same period in the prior year.

You can track ORCL financials on Quiver Quantitative's ORCL stock page.

Oracle Corporation Congressional Stock Trading

Members of Congress have traded $ORCL stock 14 times in the past 6 months. Of those trades, 6 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
• SENATOR TOMMY TUBERVILLE sold up to $50,000 on 10/07.
• REPRESENTATIVE CLEO FIELDS has traded it 3 times. They made 3 purchases worth up to $200,000 on 09/23, 09/18, 09/17 and 0 sales.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
• REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 09/15, 09/12.
• SENATOR JOHN BOOZMAN sold up to $15,000 on 09/12.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Oracle Corporation Hedge Fund Activity

We have seen 1,841 institutional investors add shares of Oracle Corporation stock to their portfolio, and 1,737 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ added 11,518,787 shares (+123.9%) to their portfolio in Q3 2025, for an estimated $3,239,543,655
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 9,369,998 shares (+61.2%) to their portfolio in Q3 2025, for an estimated $2,635,218,237
• JENNISON ASSOCIATES LLC added 8,800,546 shares (+2062.4%) to their portfolio in Q3 2025, for an estimated $2,475,065,557
• FMR LLC added 7,047,855 shares (+28.3%) to their portfolio in Q3 2025, for an estimated $1,982,138,740
• NORGES BANK added 6,255,302 shares (+47.0%) to their portfolio in Q2 2025, for an estimated $1,367,596,676
• VANGUARD GROUP INC added 4,681,626 shares (+2.8%) to their portfolio in Q3 2025, for an estimated $1,316,660,496
• BLACKROCK, INC. added 4,417,021 shares (+3.3%) to their portfolio in Q3 2025, for an estimated $1,242,242,986

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Oracle Corporation Government Contracts

We have seen $1,026,679,082 of award payments to $ORCL over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• EHRM WAVES K, L, M (VISN 23) AND N, O (VISN 15) DEPLOYMENTS: $345,933,136
• IGF::OT::IGF TASK ORDER 36C10B18N0003 UNDER IDIQ CONTRACT 36C10B18D5000 FOR OPERATIONAL MANAGEMENT SERVICES...: $217,811,814
• EHRM OPERATIONS: $113,079,612
• EHRM LICENSES AND FEES: $97,806,309
• FORMALLY RECOGNIZE THE CONTRACTORS CORPORATE NAME CHANGE FROM CERNER GOVERNMENT SERVICES INC. TO ORACLE HEA...: $82,739,388

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Oracle Corporation Analyst Ratings

Wall Street analysts have issued reports on $ORCL in the last several months. We have seen 20 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Stifel issued a "Buy" rating on 12/11/2025
• Bernstein issued a "Outperform" rating on 12/11/2025
• BMO Capital issued a "Outperform" rating on 12/11/2025
• Deutsche Bank issued a "Buy" rating on 11/26/2025
• Baird issued a "Outperform" rating on 11/18/2025
• Guggenheim issued a "Buy" rating on 10/17/2025
• Piper Sandler issued a "Overweight" rating on 10/17/2025

To track analyst ratings and price targets for Oracle Corporation, check out Quiver Quantitative's $ORCL forecast page.

Oracle Corporation Price Targets

Multiple analysts have issued price targets for $ORCL recently. We have seen 30 analysts offer price targets for $ORCL in the last 6 months, with a median target of $322.5.

Here are some recent targets:

• Kash Rangan from Goldman Sachs set a target price of $220.0 on 12/12/2025
• Brad Sills from B of A Securities set a target price of $300.0 on 12/11/2025
• Derrick Wood from TD Cowen set a target price of $350.0 on 12/11/2025
• Keith Bachman from BMO Capital set a target price of $270.0 on 12/11/2025
• Mark L. Moerdler from Bernstein set a target price of $339.0 on 12/11/2025
• Brad Reback from Stifel set a target price of $275.0 on 12/11/2025
• Hannah Rudoff from Piper Sandler set a target price of $290.0 on 12/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Robotaxi Expansion Buzz: Recent discussions on social media have centered around Grab Holdings Limited's strategic moves into autonomous vehicle technology, particularly with plans to launch robobuses in Singapore by early 2026. Many users are excited about the company's partnerships and investments in this space, seeing it as a potential growth driver. This has sparked a flurry of optimistic chatter about future market dominance in Southeast Asia.

Market Share and Competition: Another hot topic is Grab’s entrenched position as a leading super-app in the region, with some users debating its competitive edge over past rivals like Uber. Posts often highlight the company’s ability to adapt to local needs, fueling speculation about its long-term sustainability. The conversation reflects a mix of admiration and skepticism about its expansive ecosystem.

Note: This discussion summary was generated from an AI condensation of post data.

Grab Holdings Limited Hedge Fund Activity

We have seen 310 institutional investors add shares of Grab Holdings Limited stock to their portfolio, and 222 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PERPETUAL LTD removed 43,385,924 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $218,231,197
• ASPEX MANAGEMENT (HK) LTD added 28,384,511 shares (+inf%) to their portfolio in Q3 2025, for an estimated $170,874,756
• HRT FINANCIAL LP added 26,551,501 shares (+354.3%) to their portfolio in Q3 2025, for an estimated $159,840,036
• WELLINGTON MANAGEMENT GROUP LLP removed 21,024,290 shares (-39.1%) from their portfolio in Q3 2025, for an estimated $126,566,225
• CAPITAL RESEARCH GLOBAL INVESTORS removed 19,961,337 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $120,167,248
• CITIGROUP INC added 17,160,661 shares (+112.6%) to their portfolio in Q3 2025, for an estimated $103,307,179
• INVESCO LTD. added 15,916,063 shares (+24.9%) to their portfolio in Q3 2025, for an estimated $95,814,699

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Grab Holdings Limited Price Targets

Multiple analysts have issued price targets for $GRAB recently. We have seen 3 analysts offer price targets for $GRAB in the last 6 months, with a median target of $7.0.

Here are some recent targets:

• Jiong Shao from Barclays set a target price of $7.0 on 11/11/2025
• Fawne Jiang from Benchmark set a target price of $7.0 on 11/04/2025
• Piyush Choudhary from HSBC set a target price of $6.2 on 09/17/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Year-End Rally: Recent chatter on social media has highlighted Caterpillar Inc.'s impressive 61% year-to-date stock gain. Many are pointing to strong demand in energy and transport sectors as a key driver. There's also buzz about AI data center orders boosting growth prospects.

Innovation Focus: Discussions are also centering on the company's investment in robotics and autonomous technology. Users note this as a core part of their strategy for heavy machinery in construction and mining. It’s seen as a forward-thinking move amid industry shifts.

Tariff Concerns: Despite the optimism, some conversations mention potential headwinds from tariff challenges. There’s a mix of confidence in sales growth and cash flow through 2030, tempered by these external risks. The dialogue remains dynamic as investors weigh the pros and cons.

Note: This discussion summary was generated from an AI condensation of post data.

Caterpillar Inc. Insider Trading Activity

Caterpillar Inc. insiders have traded $CAT stock on the open market 29 times in the past 6 months. Of those trades, 1 have been purchases and 28 have been sales.

Here’s a breakdown of recent trading of $CAT stock by insiders over the last 6 months:

• III DONALD J UMPLEBY (Executive Chairman) has made 0 purchases and 3 sales selling 51,500 shares for an estimated $23,703,810.
• LANGE BOB DE (Group President) sold 14,638 shares for an estimated $8,231,825
• JASON KAISER (Group President) has made 0 purchases and 14 sales selling 12,868 shares for an estimated $6,937,140.
• ANDREW R J BONFIELD (Chief Financial Officer) has made 0 purchases and 7 sales selling 10,000 shares for an estimated $5,714,447.
• ANTHONY D. FASSINO (Group President) sold 8,184 shares for an estimated $4,666,353
• SUSAN C SCHWAB sold 2,324 shares for an estimated $952,840
• WILLIAM E SCHAUPP (Chief Accounting Officer) sold 1,200 shares for an estimated $686,664
• DAVID MACLENNAN purchased 300 shares for an estimated $170,658

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Caterpillar Inc. Revenue

Caterpillar Inc. had revenues of $17.6B in Q3 2025. This is an increase of 9.51% from the same period in the prior year.

You can track CAT financials on Quiver Quantitative's CAT stock page.

Caterpillar Inc. Congressional Stock Trading

Members of Congress have traded $CAT stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CAT stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Caterpillar Inc. Hedge Fund Activity

We have seen 1,433 institutional investors add shares of Caterpillar Inc. stock to their portfolio, and 1,428 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VALEO FINANCIAL ADVISORS, LLC removed 7,278,118 shares (-99.7%) from their portfolio in Q3 2025, for an estimated $3,472,754,003
• WELLINGTON MANAGEMENT GROUP LLP added 5,098,964 shares (+3949.8%) to their portfolio in Q3 2025, for an estimated $2,432,970,672
• PRICE T ROWE ASSOCIATES INC /MD/ added 4,956,952 shares (+267.1%) to their portfolio in Q3 2025, for an estimated $2,365,209,646
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,929,458 shares (+92.9%) to their portfolio in Q3 2025, for an estimated $1,874,940,884
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,736,631 shares (+1851.8%) to their portfolio in Q3 2025, for an estimated $828,633,481
• FMR LLC added 1,333,426 shares (+74.1%) to their portfolio in Q3 2025, for an estimated $636,244,215
• GATES FOUNDATION TRUST removed 1,000,000 shares (-13.6%) from their portfolio in Q3 2025, for an estimated $477,150,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Caterpillar Inc. Government Contracts

We have seen $282,153,928 of award payments to $CAT over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• 8511390294!D9R TRACTOR DOZER: $87,034,944
• 8511336920!TRACTOR DOZER: $83,357,120
• 8511272435!EXCAVATOR: $8,288,786
• CAT PARTS C-7 SUPPLY ENGINE: $6,405,000
• 8511260946!EXCAVATOR: $5,954,622

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Caterpillar Inc. Analyst Ratings

Wall Street analysts have issued reports on $CAT in the last several months. We have seen 9 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Overweight" rating on 11/14/2025
• Citigroup issued a "Buy" rating on 10/31/2025
• Truist Securities issued a "Buy" rating on 10/30/2025
• Morgan Stanley issued a "Underweight" rating on 10/30/2025
• JP Morgan issued a "Overweight" rating on 10/30/2025
• B of A Securities issued a "Buy" rating on 10/15/2025
• Oppenheimer issued a "Outperform" rating on 08/29/2025

To track analyst ratings and price targets for Caterpillar Inc., check out Quiver Quantitative's $CAT forecast page.

Caterpillar Inc. Price Targets

Multiple analysts have issued price targets for $CAT recently. We have seen 16 analysts offer price targets for $CAT in the last 6 months, with a median target of $575.0.

Here are some recent targets:

• Chad Dillard from Bernstein set a target price of $630.0 on 12/19/2025
• Kyle Menges from Citigroup set a target price of $690.0 on 12/11/2025
• Angel Castillo from Morgan Stanley set a target price of $395.0 on 12/10/2025
• Jerry Revich from Wells Fargo set a target price of $675.0 on 11/14/2025
• Helen Fang from HSBC set a target price of $660.0 on 11/06/2025
• Steven Fisher from UBS set a target price of $581.0 on 11/04/2025
• Michael Shlisky from DA Davidson set a target price of $569.0 on 11/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Representative Mike Kelly made $112.8K in the stock market last month, per Quiver Quantitative's live net worth estimates.

Representative Mike Kelly Net Worth

Quiver Quantitative estimates that Representative Mike Kelly is worth $16.1M, as of December 28th, 2025. This is the 83rd highest net worth in Congress, per our live estimates.

Kelly has approximately $5.9M invested in publicly traded assets which Quiver is able to track live.

You can track Representative Mike Kelly's net worth on Quiver Quantitative's politician page for Kelly.

Representative Mike Kelly Stock Trading

We have data on up to $6.0M of trades from Representative Mike Kelly, which we parsed from STOCK Act filings. Some of the largest trades include:

• A March 28th, 2024 purchase of up to $100K of $CLF. The stock has fallen 44.11% since then.
• A June 20th, 2025 sale of up to $50K of $X.
• A November 8th, 2024 sale of up to $50K of $UNP. The stock has fallen 0.64% since then.
• A April 12th, 2024 sale of up to $15K of $UNH. The stock has fallen 22.17% since then.
• A April 12th, 2024 sale of up to $15K of $VZ. The stock has risen 2.95% since then.

You can track Representative Mike Kelly's stock trading on Quiver Quantitative's politician page for Kelly.

Representative Mike Kelly Bill Proposals

Here are some bills which have recently been proposed by Representative Mike Kelly:

• H.R.6446: To modify the procedures for investigating claims of evasion of antidumping and countervailing duty orders.
• H.R.5275: Diagnostic Accuracy in Sepsis Act of 2025
• H.R.4566: Washington’s Trail—1753 National Historic Trail Feasibility Study Act of 2025
• H.R.4547: To advance Thomas B. Hagen on the retired list of the Navy.
• H.R.4231: Treat and Reduce Obesity Act of 2025
• H.R.4184: To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.

You can track bills proposed by Representative Mike Kelly on Quiver Quantitative's politician page for Kelly.

Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.

Senator Ted Cruz made $466.4K in the stock market last month, per Quiver Quantitative's live net worth estimates.

Senator Ted Cruz Net Worth

Quiver Quantitative estimates that Senator Ted Cruz is worth $11.1M, as of December 28th, 2025. This is the 102nd highest net worth in Congress, per our live estimates.

Cruz has approximately $5.0M invested in publicly traded assets which Quiver is able to track live.

You can track Senator Ted Cruz's net worth on Quiver Quantitative's politician page for Cruz.

Senator Ted Cruz Stock Trading

We have data on up to $1.7M of trades from Senator Ted Cruz, which we parsed from STOCK Act filings. Some of the largest trades include:

• A April 15th, 2024 sale of up to $500K of $GS. The stock has risen 121.5% since then.
• A February 3rd, 2015 purchase of up to $100K of $PAGP. The stock has fallen 74.53% since then.
• A February 25th, 2016 sale of up to $50K of $OKE. The stock has risen 244.36% since then.

You can track Senator Ted Cruz's stock trading on Quiver Quantitative's politician page for Cruz.

Senator Ted Cruz Bill Proposals

Here are some bills which have recently been proposed by Senator Ted Cruz:

• S.3418: A bill to ensure competition in health insurance markets.
• S.3263: Stop TSP ESG Act
• S.3120: Ensuring Predictable and Reliable Water Deliveries Act of 2025
• S.3113: Deporting Fraudsters Act of 2025
• S.3107: USPS Act
• S.3081: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025

You can track bills proposed by Senator Ted Cruz on Quiver Quantitative's politician page for Cruz.

Senator Ted Cruz Fundraising

Senator Ted Cruz recently disclosed $1.3M of fundraising in a Q3 FEC disclosure filed on October 15th, 2025. This was the 39th most from all Q3 reports we have seen this year. 91.6% came from individual donors.

Cruz disclosed $1.3M of spending. This was the 23rd most from all Q3 reports we have seen from politicians so far this year.

Cruz disclosed $2.5M of cash on hand at the end of the filing period. This was the 137th most from all Q3 reports we have seen this year.

You can see the disclosure here, or track Senator Ted Cruz's fundraising on Quiver Quantitative.

Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.

Representative Bill Foster made $198.9K in the stock market last month, per Quiver Quantitative's live net worth estimates.

Representative Bill Foster Net Worth

Quiver Quantitative estimates that Representative Bill Foster is worth $20.1M, as of December 28th, 2025. This is the 67th highest net worth in Congress, per our live estimates.

Foster has approximately $9.9M invested in publicly traded assets which Quiver is able to track live.

You can track Representative Bill Foster's net worth on Quiver Quantitative's politician page for Foster.

Representative Bill Foster Bill Proposals

Here are some bills which have recently been proposed by Representative Bill Foster:

• H.R.6741: To assess the State by State impact of Federal taxation and spending.
• H.R.6686: To amend section 262 of the Museum and Library Services Act to authorize the Director of the Institute of Museum and Library Services to award grants to institutions of higher education for courses that use only publicly available digital resources for required reading assignments, and for other purposes.
• H.R.6571: To require disclosure of the use of content by Federal officials that is created or manipulated using generative artificial intelligence in their publications, and for other purposes.
• H.R.4496: Restore and Modernize Our National Laboratories Act of 2025
• H.R.4402: DASHBOARD Act of 2025
• H.R.3682: Financial Stability Oversight Council Improvement Act of 2025

You can track bills proposed by Representative Bill Foster on Quiver Quantitative's politician page for Foster.

Representative Bill Foster Fundraising

Representative Bill Foster recently disclosed $307.8K of fundraising in a Q3 FEC disclosure filed on October 15th, 2025. This was the 310th most from all Q3 reports we have seen this year. 71.9% came from individual donors.

Foster disclosed $148.0K of spending. This was the 418th most from all Q3 reports we have seen from politicians so far this year.

Foster disclosed $2.0M of cash on hand at the end of the filing period. This was the 175th most from all Q3 reports we have seen this year.

You can see the disclosure here, or track Representative Bill Foster's fundraising on Quiver Quantitative.

Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.

Representative Jefferson Shreve lost $838.1K in the stock market last month, per Quiver Quantitative's live net worth estimates.

Representative Jefferson Shreve Net Worth

Quiver Quantitative estimates that Representative Jefferson Shreve is worth $596.6M, as of December 28th, 2025. This is the 2nd highest net worth in Congress, per our live estimates.

Shreve has approximately $46.9M invested in publicly traded assets which Quiver is able to track live.

You can track Representative Jefferson Shreve's net worth on Quiver Quantitative's politician page for Shreve.

Representative Jefferson Shreve Stock Trading

We have data on up to $94.8M of trades from Representative Jefferson Shreve, which we parsed from STOCK Act filings. Some of the largest trades include:

• A May 12th, 2025 sale of up to $1M of $NVDA. The stock has risen 42.29% since then.
• A May 12th, 2025 sale of up to $1M of $MSFT. The stock has risen 6.52% since then.
• A May 8th, 2025 sale of up to $1M of $AAPL. The stock has risen 40.91% since then.
• A May 12th, 2025 sale of up to $500K of $AMZN. The stock has risen 8.41% since then.
• A May 12th, 2025 sale of up to $250K of $GOOGL. The stock has risen 95.18% since then.

You can track Representative Jefferson Shreve's stock trading on Quiver Quantitative's politician page for Shreve.

Representative Jefferson Shreve Bill Proposals

Here are some bills which have recently been proposed by Representative Jefferson Shreve:

• H.R.5980: Mexico Cross-Border Crime Accountability Act
• H.R.5490: Dismantle Foreign Scam Syndicates Act
• H.R.4531: BANNED in Latin America Act
• H.R.3934: Water Quality Standards Attainability Act
• H.R.3523: To require the Secretary of the Treasury to designate certain covered organizations as Foreign Financial Threat Organizations, and for other purposes.
• H.R.3426: Courthouse Affordability and Space Efficiency Act of 2025

You can track bills proposed by Representative Jefferson Shreve on Quiver Quantitative's politician page for Shreve.

Representative Jefferson Shreve Fundraising

Representative Jefferson Shreve recently disclosed $99.3K of fundraising in a Q3 FEC disclosure filed on October 14th, 2025. This was the 715th most from all Q3 reports we have seen this year. 44.6% came from individual donors.

Shreve disclosed $82.6K of spending. This was the 648th most from all Q3 reports we have seen from politicians so far this year.

Shreve disclosed $1.1M of cash on hand at the end of the filing period. This was the 314th most from all Q3 reports we have seen this year.

You can see the disclosure here, or track Representative Jefferson Shreve's fundraising on Quiver Quantitative.

Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.

Senator Bill Hagerty made $238.0K in the stock market last month, per Quiver Quantitative's live net worth estimates.

Senator Bill Hagerty Net Worth

Quiver Quantitative estimates that Senator Bill Hagerty is worth $53.0M, as of December 28th, 2025. This is the 32nd highest net worth in Congress, per our live estimates.

Hagerty has approximately $17.0M invested in publicly traded assets which Quiver is able to track live.

You can track Senator Bill Hagerty's net worth on Quiver Quantitative's politician page for Hagerty.

Senator Bill Hagerty Stock Trading

We have data on up to $53.9M of trades from Senator Bill Hagerty, which we parsed from STOCK Act filings. Some of the largest trades include:

• A November 8th, 2021 sale of up to $5M of $DDOG. The stock has fallen 23.7% since then.
• A December 23rd, 2021 sale of up to $500K of $RNR. The stock has risen 62.48% since then.
• A December 29th, 2021 sale of up to $250K of $PNFP. The stock has risen 4.09% since then.
• A December 23rd, 2021 sale of up to $250K of $RHP. The stock has risen 9.92% since then.
• A December 29th, 2021 sale of up to $100K of $NS. The stock has risen 45.91% since then.

You can track Senator Bill Hagerty's stock trading on Quiver Quantitative's politician page for Hagerty.

Senator Bill Hagerty Bill Proposals

Here are some bills which have recently been proposed by Senator Bill Hagerty:

• S.3290: Financial Services and General Government Appropriations Act, 2026
• S.3129: Preventing Foreign Interference in American Elections Act
• S.2999: Main Street Depositor Protection Act
• S.2840: Financial Exploitation Prevention Act of 2025
• S.2553: Protect Our Communities from DUIs Act
• S.2484: NeighborWorks Accountability Act

You can track bills proposed by Senator Bill Hagerty on Quiver Quantitative's politician page for Hagerty.

Senator Bill Hagerty Fundraising

Senator Bill Hagerty recently disclosed $851.6K of fundraising in a Q3 FEC disclosure filed on October 15th, 2025. This was the 64th most from all Q3 reports we have seen this year. 65.5% came from individual donors.

Hagerty disclosed $358.2K of spending. This was the 145th most from all Q3 reports we have seen from politicians so far this year.

Hagerty disclosed $4.6M of cash on hand at the end of the filing period. This was the 59th most from all Q3 reports we have seen this year.

You can see the disclosure here, or track Senator Bill Hagerty's fundraising on Quiver Quantitative.

Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.

Representative Gregory F. Murphy made $137.1K in the stock market last month, per Quiver Quantitative's live net worth estimates.

Representative Gregory F. Murphy Net Worth

Quiver Quantitative estimates that Representative Gregory F. Murphy is worth $24.3M, as of December 28th, 2025. This is the 54th highest net worth in Congress, per our live estimates.

Murphy has approximately $12.4M invested in publicly traded assets which Quiver is able to track live.

You can track Representative Gregory F. Murphy's net worth on Quiver Quantitative's politician page for Murphy.

Representative Gregory F. Murphy Stock Trading

We have data on up to $700.0K of trades from Representative Gregory F. Murphy, which we parsed from STOCK Act filings. Some of the largest trades include:

• A January 22nd, 2021 sale of up to $100K of $NYMX. The stock has fallen 91.67% since then.

You can track Representative Gregory F. Murphy's stock trading on Quiver Quantitative's politician page for Murphy.

Representative Gregory F. Murphy Bill Proposals

Here are some bills which have recently been proposed by Representative Gregory F. Murphy:

• H.R.6721: To amend title XVIII of the Social Security Act to encourage Medicare beneficiaries to voluntarily adopt advance directives guiding the medical care they receive.
• H.R.6663: Campus Free Speech Restoration Act
• H.R.6662: To direct the Secretary of Defense and the Secretary of Veterans Affairs to jointly select a joint uniform credentialing and privileging system for medical providers, and for other purposes.
• H.R.6583: To amend title 38, United States Code, to establish a centralized research data system for the Department of Veterans Affairs and to make certain improvements to processes applicable to major research projects of the Department, and for other purposes.
• H.R.6504: Haiti Economic Lift Program Extension Act
• H.R.6219: To amend title XVIII of the Social Security Act to prohibit approved medical residency training programs under Medicare program from requiring opt-out abortion training.

You can track bills proposed by Representative Gregory F. Murphy on Quiver Quantitative's politician page for Murphy.

Representative Gregory F. Murphy Fundraising

Representative Gregory F. Murphy recently disclosed $202.1K of fundraising in a Q3 FEC disclosure filed on October 15th, 2025. This was the 459th most from all Q3 reports we have seen this year. 55.1% came from individual donors.

Murphy disclosed $239.6K of spending. This was the 226th most from all Q3 reports we have seen from politicians so far this year.

Murphy disclosed $2.1M of cash on hand at the end of the filing period. This was the 165th most from all Q3 reports we have seen this year.

You can see the disclosure here, or track Representative Gregory F. Murphy's fundraising on Quiver Quantitative.

Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.

$80,000 of MCCORMICK & COMPANY INCORPORATED lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to tariffs Issues related to upcoming tax debate"

You can find more data on corporate lobbying on Quiver Quantitative.

MKC Congressional Stock Trading

Members of Congress have traded $MKC stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $MKC stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 09/25.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/22 and 1 sale worth up to $15,000 on 08/04.
• REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MKC Insider Trading Activity

MKC insiders have traded $MKC stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $MKC stock by insiders over the last 6 months:

• LAWRENCE ERIK KURZIUS has made 0 purchases and 6 sales selling 89,014 shares for an estimated $5,810,963.
• BRENDAN M FOLEY (Chairman, President & CEO) sold 57,144 shares for an estimated $3,746,360

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MKC Hedge Fund Activity

We have seen 402 institutional investors add shares of MKC stock to their portfolio, and 615 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,543,514 shares (+70.0%) to their portfolio in Q3 2025, for an estimated $170,186,521
• INVESCO LTD. added 2,494,544 shares (+66.7%) to their portfolio in Q3 2025, for an estimated $166,909,939
• CITADEL ADVISORS LLC added 2,415,147 shares (+545.7%) to their portfolio in Q3 2025, for an estimated $161,597,485
• SELECT EQUITY GROUP, L.P. removed 1,560,869 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $118,345,087
• FMR LLC added 1,403,154 shares (+338.6%) to their portfolio in Q3 2025, for an estimated $93,885,034
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 1,203,287 shares (-31.2%) from their portfolio in Q3 2025, for an estimated $80,511,933
• VOYA INVESTMENT MANAGEMENT LLC removed 1,193,964 shares (-50.0%) from their portfolio in Q3 2025, for an estimated $79,888,131

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MKC Analyst Ratings

Wall Street analysts have issued reports on $MKC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Overweight" rating on 09/25/2025

To track analyst ratings and price targets for MKC, check out Quiver Quantitative's $MKC forecast page.

MKC Price Targets

Multiple analysts have issued price targets for $MKC recently. We have seen 7 analysts offer price targets for $MKC in the last 6 months, with a median target of $72.0.

Here are some recent targets:

• Andrew Lazar from Barclays set a target price of $72.0 on 10/08/2025
• Alexia Howard from Bernstein set a target price of $93.0 on 10/08/2025
• Stephen Powers from Deutsche Bank set a target price of $71.0 on 10/08/2025
• Matthew Smith from Stifel set a target price of $71.0 on 10/08/2025
• Rob Dickerson from Jefferies set a target price of $78.0 on 10/08/2025
• Bryan Adams from UBS set a target price of $70.0 on 10/08/2025
• Thomas Palmer from JP Morgan set a target price of $82.0 on 09/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of UMH PROPERTIES INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues affecting manufactured home communities"

You can find more data on corporate lobbying on Quiver Quantitative.

UMH Insider Trading Activity

UMH insiders have traded $UMH stock on the open market 16 times in the past 6 months. Of those trades, 8 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $UMH stock by insiders over the last 6 months:

• WILLIAM EDWARD MITCHELL has made 1 purchase buying 2,000 shares for an estimated $29,840 and 3 sales selling 116,849 shares for an estimated $1,890,685.
• SAMUEL A LANDY (President and CEO) has made 0 purchases and 4 sales selling 97,800 shares for an estimated $1,511,976.
• MICHAEL P LANDY purchased 10,000 shares for an estimated $144,600
• ANGELA D. PRUITT sold 1,600 shares for an estimated $25,695
• TODD J. CLARK has made 2 purchases buying 599 shares for an estimated $8,502 and 0 sales.
• JEFFREY A CARUS has made 4 purchases buying 209 shares for an estimated $3,000 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UMH Hedge Fund Activity

We have seen 157 institutional investors add shares of UMH stock to their portfolio, and 100 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,958,912 shares (-32.1%) from their portfolio in Q3 2025, for an estimated $29,089,843
• CAPITAL RESEARCH GLOBAL INVESTORS removed 1,800,000 shares (-32.9%) from their portfolio in Q3 2025, for an estimated $26,730,000
• COPELAND CAPITAL MANAGEMENT, LLC removed 959,514 shares (-37.6%) from their portfolio in Q3 2025, for an estimated $14,248,782
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 536,004 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $7,959,659
• PRIVATE MANAGEMENT GROUP INC added 461,463 shares (+37.9%) to their portfolio in Q3 2025, for an estimated $6,852,725
• CITIGROUP INC added 445,834 shares (+141.8%) to their portfolio in Q3 2025, for an estimated $6,620,634
• BLACKROCK, INC. added 400,845 shares (+5.5%) to their portfolio in Q3 2025, for an estimated $5,952,548

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UMH Analyst Ratings

Wall Street analysts have issued reports on $UMH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Colliers Securities issued a "Buy" rating on 12/04/2025
• B. Riley Securities issued a "Buy" rating on 11/24/2025

To track analyst ratings and price targets for UMH, check out Quiver Quantitative's $UMH forecast page.

UMH Price Targets

Multiple analysts have issued price targets for $UMH recently. We have seen 3 analysts offer price targets for $UMH in the last 6 months, with a median target of $17.0.

Here are some recent targets:

• Barry Oxford from Colliers Securities set a target price of $17.0 on 12/04/2025
• John Massocca from B. Riley Securities set a target price of $18.5 on 11/24/2025
• Richard Anderson from Cantor Fitzgerald set a target price of $15.0 on 10/01/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Nvidia Investment Buzz: Recent online conversations have been dominated by news of a significant $2 billion investment from Nvidia into Synopsys, Inc. This partnership aims to advance chip design and AI applications, sparking excitement among many observers. The strategic move is seen as a potential game-changer for the semiconductor industry.

Legal Challenges Surface: Alongside the positive buzz, discussions on social media also highlight a wave of securities class action lawsuits against Synopsys. These legal actions, tied to alleged underperformance in the company’s Design IP business, have raised concerns for some investors. The looming legal deadline has kept the topic trending in online forums.

Note: This discussion summary was generated from an AI condensation of post data.

Synopsys, Inc. Insider Trading Activity

Synopsys, Inc. insiders have traded $SNPS stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $SNPS stock by insiders over the last 6 months:

• SUDHINDRA KANKANWADI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 15,873 shares for an estimated $7,837,408.
• SASSINE GHAZI (PRESIDENT AND CEO) sold 11,366 shares for an estimated $6,694,725
• SHELAGH GLASER (CFO) has made 0 purchases and 4 sales selling 7,312 shares for an estimated $3,913,745.
• ROBERT G PAINTER purchased 350 shares for an estimated $148,903

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Synopsys, Inc. Revenue

Synopsys, Inc. had revenues of $2.3B in Q4 2025. This is an increase of 37.83% from the same period in the prior year.

You can track SNPS financials on Quiver Quantitative's SNPS stock page.

Synopsys, Inc. Congressional Stock Trading

Members of Congress have traded $SNPS stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $SNPS stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 11/18, 10/09.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 08/13 and 1 sale worth up to $15,000 on 09/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Synopsys, Inc. Hedge Fund Activity

We have seen 983 institutional investors add shares of Synopsys, Inc. stock to their portfolio, and 569 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 3,120,401 shares (+20.7%) to their portfolio in Q3 2025, for an estimated $1,539,574,649
• MORGAN STANLEY added 2,600,089 shares (+139.5%) to their portfolio in Q3 2025, for an estimated $1,282,857,911
• BLACKROCK, INC. added 2,371,463 shares (+18.5%) to their portfolio in Q3 2025, for an estimated $1,170,056,129
• PRICE T ROWE ASSOCIATES INC /MD/ removed 2,001,274 shares (-37.6%) from their portfolio in Q3 2025, for an estimated $987,408,578
• VICTORY CAPITAL MANAGEMENT INC added 1,990,608 shares (+238.8%) to their portfolio in Q3 2025, for an estimated $982,146,081
• FMR LLC added 1,868,243 shares (+47.5%) to their portfolio in Q3 2025, for an estimated $921,772,413
• COATUE MANAGEMENT LLC added 1,809,127 shares (+inf%) to their portfolio in Q3 2025, for an estimated $892,605,170

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Synopsys, Inc. Government Contracts

We have seen $380,206 of award payments to $SNPS over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• TO RENEW CODE V/ETD: $112,238
• PURCHASE SOFTWARE FOR TCAD FABRICATION PROCESS SIMULATION: $110,100
• SYNPLIFY BASE PERPETUAL MAINTENANCE: $43,940
• SYNOPSYS SYNPLIFY SOFTWARE LICENSE: $33,800
• .1. THE PURPOSE OF ORDER W56JSR-23-P-0009 IS TO PROVIDE SUBSCRIPTION FIRM-FIXED-PRICE (FFP) SYNOPSIS SYNP...: $33,420

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Synopsys, Inc. Analyst Ratings

Wall Street analysts have issued reports on $SNPS in the last several months. We have seen 11 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• B of A Securities issued a "Buy" rating on 12/11/2025
• Rosenblatt issued a "Buy" rating on 12/11/2025
• Citigroup issued a "Buy" rating on 11/24/2025
• Exane BNP Paribas issued a "Underperform" rating on 10/02/2025
• Morgan Stanley issued a "Overweight" rating on 09/11/2025
• Mizuho issued a "Outperform" rating on 09/11/2025
• Stifel issued a "Buy" rating on 09/10/2025

To track analyst ratings and price targets for Synopsys, Inc., check out Quiver Quantitative's $SNPS forecast page.

Synopsys, Inc. Price Targets

Multiple analysts have issued price targets for $SNPS recently. We have seen 14 analysts offer price targets for $SNPS in the last 6 months, with a median target of $570.0.

Here are some recent targets:

• Lee Simpson from Morgan Stanley set a target price of $550.0 on 12/12/2025
• Jason Celino from Keybanc set a target price of $600.0 on 12/11/2025
• Clarke Jeffries from Piper Sandler set a target price of $602.0 on 12/11/2025
• Joe Quatrochi from Wells Fargo set a target price of $500.0 on 12/11/2025
• Blair Abernethy from Rosenblatt set a target price of $560.0 on 12/11/2025
• Vivek Arya from B of A Securities set a target price of $560.0 on 12/11/2025
• Charles Shi from Needham set a target price of $580.0 on 12/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

New Product Launch: Recent buzz on social media has centered around Lincoln National Corporation's launch of a new Capital Group ETF indexed account for its fixed indexed annuities. Many users are intrigued by the product's promise of equity exposure with full downside protection, seeing it as a strategic move in the current market.

Stock Performance Surge: Discussions also highlight the stock's impressive performance, with a 16% rise over the past month and over 45% year-to-date gains. Some voices on social media are optimistic, pointing to technical indicators like breakouts and bullish patterns as signs of continued momentum. A few have even called the stock undervalued given its recent trajectory.

Analyst Updates: The recent price target increase by Piper Sandler to $48 from $42 has sparked additional chatter. Social media reflects curiosity about whether this neutral rating aligns with the stock's strong upward trend, with some questioning if more upgrades are on the horizon.

Note: This discussion summary was generated from an AI condensation of post data.

Lincoln National Corporation Insider Trading Activity

Lincoln National Corporation insiders have traded $LNC stock on the open market 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $LNC stock by insiders over the last 6 months:

• SEAN WOODROFFE (EVP, Ch Ppl Culture Comms Off) sold 16,164 shares for an estimated $661,107
• JOHN CHRISTOPHER KENNEDY (EVP, Chief Dist. & Brand Off) has made 0 purchases and 2 sales selling 8,519 shares for an estimated $351,813.
• BRIAN KROLL (EVP, Head of Life & Annuities) sold 6,362 shares for an estimated $260,014
• OWEN RYAN purchased 2,000 shares for an estimated $84,340

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Lincoln National Corporation Revenue

Lincoln National Corporation had revenues of $4.6B in Q3 2025. This is an increase of 10.8% from the same period in the prior year.

You can track LNC financials on Quiver Quantitative's LNC stock page.

Lincoln National Corporation Hedge Fund Activity

We have seen 284 institutional investors add shares of Lincoln National Corporation stock to their portfolio, and 291 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BLACKROCK, INC. added 1,944,841 shares (+11.8%) to their portfolio in Q3 2025, for an estimated $78,435,437
• PRICE T ROWE ASSOCIATES INC /MD/ added 1,403,500 shares (+36.9%) to their portfolio in Q3 2025, for an estimated $56,603,155
• HENNESSY ADVISORS INC removed 1,402,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $56,542,660
• VANGUARD GROUP INC added 1,183,934 shares (+6.3%) to their portfolio in Q3 2025, for an estimated $47,748,058
• DIMENSIONAL FUND ADVISORS LP added 1,157,599 shares (+25.3%) to their portfolio in Q3 2025, for an estimated $46,685,967
• JENNISON ASSOCIATES LLC added 1,056,710 shares (+83.7%) to their portfolio in Q3 2025, for an estimated $42,617,114
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,035,505 shares (+21.1%) to their portfolio in Q3 2025, for an estimated $41,761,916

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Lincoln National Corporation Analyst Ratings

Wall Street analysts have issued reports on $LNC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 10/07/2025

To track analyst ratings and price targets for Lincoln National Corporation, check out Quiver Quantitative's $LNC forecast page.

Lincoln National Corporation Price Targets

Multiple analysts have issued price targets for $LNC recently. We have seen 12 analysts offer price targets for $LNC in the last 6 months, with a median target of $45.0.

Here are some recent targets:

• John Barnidge from Piper Sandler set a target price of $48.0 on 12/23/2025
• Yaron Kinar from Mizuho set a target price of $52.0 on 12/16/2025
• Suneet Kamath from Jefferies set a target price of $59.0 on 12/15/2025
• Ryan Krueger from Keefe, Bruyette & Woods set a target price of $44.0 on 11/03/2025
• Brian Meredith from UBS set a target price of $43.0 on 10/31/2025
• Thomas Gallagher from Evercore ISI Group set a target price of $46.0 on 10/09/2025
• Alex Scott from Barclays set a target price of $46.0 on 10/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Leadership Transition: Recent discussions on social media have highlighted Comcast's announcement of a new employment agreement for Michael Cavanagh as Co-CEO, effective January 2026. Many users are intrigued by the reported $35 million stock award tied to his contract extension through 2029. This move has sparked curiosity about the company's future strategic direction.

Theme Park Expansion: Another hot topic is Comcast’s Universal Studios planning a multibillion-dollar theme park in Saudi Arabia. Social media chatter reflects excitement over the potential for growth in the entertainment sector, though some question the risks of such a massive investment. The blend of optimism and caution keeps the conversation lively.

Stock Performance Buzz: Finally, there’s notable discussion around Comcast’s stock trajectory, with some users pointing to a perceived trend reversal since October 2025. Posts often mention analyst ratings suggesting a moderate buy, fueling debates on whether the stock has room to climb. This mix of technical analysis and speculation keeps engagement high.

Note: This discussion summary was generated from an AI condensation of post data.

Comcast Revenue

Comcast had revenues of $31.2B in Q3 2025. This is a decrease of -2.72% from the same period in the prior year.

You can track CMCSA financials on Quiver Quantitative's CMCSA stock page.

Comcast Congressional Stock Trading

Members of Congress have traded $CMCSA stock 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $CMCSA stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 0 purchases and 4 sales worth up to $60,000 on 11/18, 11/12, 10/09, 08/05.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 11/13, 08/14.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
• REPRESENTATIVE SCOTT FRANKLIN has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 08/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Comcast Hedge Fund Activity

We have seen 863 institutional investors add shares of Comcast stock to their portfolio, and 1,406 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO removed 20,842,900 shares (-19.8%) from their portfolio in Q3 2025, for an estimated $654,883,918
• BLACKROCK, INC. added 19,581,123 shares (+6.5%) to their portfolio in Q3 2025, for an estimated $615,238,884
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 17,033,024 shares (+45.3%) to their portfolio in Q3 2025, for an estimated $535,177,614
• PRICE T ROWE ASSOCIATES INC /MD/ removed 13,186,740 shares (-37.3%) from their portfolio in Q3 2025, for an estimated $414,327,370
• CAPITAL WORLD INVESTORS removed 12,638,145 shares (-9.8%) from their portfolio in Q3 2025, for an estimated $397,090,515
• CAPITAL RESEARCH GLOBAL INVESTORS added 10,633,206 shares (+46.1%) to their portfolio in Q3 2025, for an estimated $334,095,332
• ALLIANCEBERNSTEIN L.P. removed 9,952,848 shares (-55.7%) from their portfolio in Q3 2025, for an estimated $312,718,484

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Comcast Government Contracts

We have seen $716,373 of award payments to $CMCSA over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• CABLE SERVICE FOR MEDICAL CENTER AND CLC: $150,840
• BPA FOR COMMERCIAL BUSINESS CABLE AND INTERNET SERVICES ON JBA: $117,733
• CIO COMCAST INTERNET BPA OY1: $59,887
• TITLE: FY 2025 COMCAST SERVICES REQUESTOR: NICOLE MARIE HAMILTON POP DATES: 10/01/2024 TO 09/30/2025 FUND T...: $55,790
• Q2Q PRO IDIOM CABLE TV SERVICE FOR 285 DROP LOCATIONS: $50,439

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Comcast Analyst Ratings

Wall Street analysts have issued reports on $CMCSA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 11/03/2025
• TD Cowen issued a "Buy" rating on 10/31/2025

To track analyst ratings and price targets for Comcast, check out Quiver Quantitative's $CMCSA forecast page.

Comcast Price Targets

Multiple analysts have issued price targets for $CMCSA recently. We have seen 15 analysts offer price targets for $CMCSA in the last 6 months, with a median target of $35.0.

Here are some recent targets:

• Benjamin Swinburne from Morgan Stanley set a target price of $31.0 on 12/10/2025
• Barton Crockett from Rosenblatt set a target price of $30.0 on 12/01/2025
• Michael Rollins from Citigroup set a target price of $35.0 on 11/03/2025
• Michael Ng from Goldman Sachs set a target price of $30.0 on 11/03/2025
• Kannan Venkateshwar from Barclays set a target price of $30.0 on 11/03/2025
• Laurent Yoon from Bernstein set a target price of $34.0 on 10/31/2025
• Sebastiano Petti from JP Morgan set a target price of $33.0 on 10/31/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Eczema Drug Setback: Recent discussions on social media have centered on Johnson & Johnson's decision to halt a mid-stage trial for an experimental eczema drug due to insufficient efficacy. Many users expressed disappointment over the setback, as it raises concerns about the company’s pipeline strength. This news has sparked debates about potential impacts on future revenue growth.

Legal Challenges Loom: Another hot topic is the ongoing legal battles, particularly a significant talc-related verdict worth $1.5 billion. Social media conversations highlight fears that with over 60,000 cases still pending, these liabilities could weigh heavily on the stock’s performance. Some are questioning if innovation can offset these persistent risks.

Mixed Market Views: Opinions on the stock’s valuation are split, with some on social media calling it a strong buy due to solid fundamentals, while others warn of a potential drop citing insider selling. The stock’s low volatility has been praised by a few as a safe haven in uncertain markets. These contrasting views keep the discussion lively and dynamic.

Note: This discussion summary was generated from an AI condensation of post data.

Johnson & Johnson Insider Trading Activity

Johnson & Johnson insiders have traded $JNJ stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $JNJ stock by insiders over the last 6 months:

• JOAQUIN DUATO (CEO and Chairman of the Board) sold 125,824 shares for an estimated $22,548,654
• JENNIFER L TAUBERT (EVP, WWC. Innovative Medicine) sold 56,471 shares for an estimated $10,040,882
• JOHN C REED (EVP, Innovative Medicine, R&D) has made 0 purchases and 2 sales selling 40,858 shares for an estimated $7,315,622.
• JOSEPH J WOLK (Exec VP, CFO) sold 16,820 shares for an estimated $2,975,570
• JOHN G MORIKIS purchased 1,250 shares for an estimated $257,687

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Johnson & Johnson Revenue

Johnson & Johnson had revenues of $24B in Q3 2025. This is an increase of 6.77% from the same period in the prior year.

You can track JNJ financials on Quiver Quantitative's JNJ stock page.

Johnson & Johnson Congressional Stock Trading

Members of Congress have traded $JNJ stock 13 times in the past 6 months. Of those trades, 3 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $JNJ stock by members of Congress over the last 6 months:

• REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 11/20, 07/31.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 11/13, 08/14.
• REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 10/30, 08/04 and 2 sales worth up to $30,000 on 10/31, 10/30.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 10/10.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
• REPRESENTATIVE KELLY MORRISON sold up to $15,000 on 08/19.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Johnson & Johnson Hedge Fund Activity

We have seen 1,957 institutional investors add shares of Johnson & Johnson stock to their portfolio, and 2,032 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 12,124,049 shares (+61.6%) to their portfolio in Q3 2025, for an estimated $2,248,041,165
• GQG PARTNERS LLC added 5,988,242 shares (+12137.4%) to their portfolio in Q3 2025, for an estimated $1,110,339,831
• GEODE CAPITAL MANAGEMENT, LLC removed 4,394,021 shares (-7.2%) from their portfolio in Q3 2025, for an estimated $814,739,373
• BLACKROCK, INC. added 3,411,739 shares (+1.7%) to their portfolio in Q3 2025, for an estimated $632,604,645
• FLOSSBACH VON STORCH SE removed 3,347,823 shares (-52.8%) from their portfolio in Q3 2025, for an estimated $620,753,340
• CAPITAL INTERNATIONAL INVESTORS added 3,266,354 shares (+545.6%) to their portfolio in Q3 2025, for an estimated $605,647,358
• PACER ADVISORS, INC. removed 2,632,092 shares (-84.2%) from their portfolio in Q3 2025, for an estimated $488,042,498

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Johnson & Johnson Government Contracts

We have seen $28,180,944 of award payments to $JNJ over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• 4566846440!TRILEAP MODULAR 1ST MTP SYSTEM: $506,953
• 4568561541!6.5MM/7.3MM CANNULATED SCREW INSTRUMENT: $270,118
• 4568528079!2.7MM/3.5MM VA-LCP ELBOW: $241,322
• 4568544902!SET INSTRMNT IMPLNT 1S: $236,585
• 4567327302!MATRIXORTHOGNATHIC PLATING: $231,995

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Johnson & Johnson Analyst Ratings

Wall Street analysts have issued reports on $JNJ in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Goldman Sachs issued a "Buy" rating on 12/19/2025
• Guggenheim issued a "Buy" rating on 12/05/2025
• UBS issued a "Buy" rating on 10/14/2025
• Citigroup issued a "Buy" rating on 10/07/2025
• Wells Fargo issued a "Overweight" rating on 10/03/2025
• RBC Capital issued a "Outperform" rating on 07/17/2025

To track analyst ratings and price targets for Johnson & Johnson, check out Quiver Quantitative's $JNJ forecast page.

Johnson & Johnson Price Targets

Multiple analysts have issued price targets for $JNJ recently. We have seen 14 analysts offer price targets for $JNJ in the last 6 months, with a median target of $210.5.

Here are some recent targets:

• Asad Haider from Goldman Sachs set a target price of $240.0 on 12/19/2025
• Tim Anderson from B of A Securities set a target price of $220.0 on 12/15/2025
• Terence Flynn from Morgan Stanley set a target price of $197.0 on 12/12/2025
• Joanne Wuensch from Citigroup set a target price of $232.0 on 12/11/2025
• Shagun Singh from RBC Capital set a target price of $230.0 on 12/11/2025
• Vamil Divan from Guggenheim set a target price of $227.0 on 12/05/2025
• Matt Miksic from Barclays set a target price of $197.0 on 12/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent Stock Performance: Nucor Corporation has seen a notable uptick in attention on social media following a recent 1.1% increase in its stock price to $165.49. Investors are actively discussing this momentum, with some pointing to strong institutional buying as a sign of confidence in the company’s outlook. The chatter highlights optimism around Nucor’s ability to navigate market fluctuations.

Earnings Anticipation: Discussions have also centered on Nucor’s upcoming fiscal fourth-quarter earnings report, with expectations of double-digit profit growth. Many are intrigued by the potential for sustained growth, especially as the company continues to position itself as a leader in the steel industry. There’s a keen interest in how the earnings will shape future sentiment.

Insider Activity: Another focal point is the recent sale of shares by Nucor’s CEO, totaling nearly $790,000, which has sparked mixed reactions online. While some see it as a routine transaction, others are questioning the timing ahead of key financial updates. The debate keeps the stock in the spotlight as opinions diverge.

Note: This discussion summary was generated from an AI condensation of post data.

Nucor Corporation Insider Trading Activity

Nucor Corporation insiders have traded $NUE stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales.

Here’s a breakdown of recent trading of $NUE stock by insiders over the last 6 months:

• LEON J TOPALIAN (Chair, President and CEO) has made 0 purchases and 5 sales selling 34,830 shares for an estimated $5,063,593.
• ALLEN C BEHR (Executive Vice President) has made 0 purchases and 3 sales selling 23,013 shares for an estimated $3,457,398.
• KENNETH REX QUERY (Executive Vice President) sold 10,000 shares for an estimated $1,449,019
• DANIEL R. NEEDHAM (Executive Vice President) sold 7,200 shares for an estimated $1,051,200
• JOHN J HOLLATZ (Executive Vice President) has made 0 purchases and 2 sales selling 7,000 shares for an estimated $1,049,160.
• MICHAEL D KELLER (Vice Pres. and Corp. Contro) has made 0 purchases and 2 sales selling 6,088 shares for an estimated $903,521.
• STEPHEN D LAXTON (CFO and EVP) has made 0 purchases and 9 sales selling 2,003 shares for an estimated $303,599.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Nucor Corporation Revenue

Nucor Corporation had revenues of $8.5B in Q3 2025. This is an increase of 14.47% from the same period in the prior year.

You can track NUE financials on Quiver Quantitative's NUE stock page.

Nucor Corporation Hedge Fund Activity

We have seen 564 institutional investors add shares of Nucor Corporation stock to their portfolio, and 593 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SLATE PATH CAPITAL LP added 1,537,300 shares (+inf%) to their portfolio in Q3 2025, for an estimated $208,196,539
• THRIVENT FINANCIAL FOR LUTHERANS added 986,333 shares (+2244.7%) to their portfolio in Q3 2025, for an estimated $133,579,078
• VANGUARD GROUP INC removed 907,566 shares (-3.1%) from their portfolio in Q3 2025, for an estimated $122,911,663
• GREENWICH WEALTH MANAGEMENT LLC removed 699,866 shares (-73.6%) from their portfolio in Q3 2025, for an estimated $94,782,852
• BLACKROCK, INC. removed 696,459 shares (-3.6%) from their portfolio in Q3 2025, for an estimated $94,321,442
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 654,818 shares (+41.6%) to their portfolio in Q3 2025, for an estimated $88,682,001
• DIMENSIONAL FUND ADVISORS LP removed 545,410 shares (-17.1%) from their portfolio in Q3 2025, for an estimated $73,864,876

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Nucor Corporation Analyst Ratings

Wall Street analysts have issued reports on $NUE in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Overweight" rating on 12/18/2025
• Jefferies issued a "Buy" rating on 12/10/2025
• Citigroup issued a "Buy" rating on 10/30/2025
• UBS issued a "Buy" rating on 10/29/2025
• Morgan Stanley issued a "Overweight" rating on 10/28/2025
• JP Morgan issued a "Overweight" rating on 10/13/2025
• B of A Securities issued a "Buy" rating on 09/15/2025

To track analyst ratings and price targets for Nucor Corporation, check out Quiver Quantitative's $NUE forecast page.

Nucor Corporation Price Targets

Multiple analysts have issued price targets for $NUE recently. We have seen 8 analysts offer price targets for $NUE in the last 6 months, with a median target of $172.0.

Here are some recent targets:

• Timna Tanners from Wells Fargo set a target price of $176.0 on 12/18/2025
• Christopher LeFemina from Jefferies set a target price of $190.0 on 12/10/2025
• Bill Peterson from JP Morgan set a target price of $200.0 on 12/05/2025
• Alexander Hacking from Citigroup set a target price of $180.0 on 10/30/2025
• Curt Woodworth from UBS set a target price of $168.0 on 10/29/2025
• Carlos De Alba from Morgan Stanley set a target price of $165.0 on 10/28/2025
• Lawson Winder from B of A Securities set a target price of $165.0 on 09/15/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Recent Stock Performance: Amgen Inc. has been a focal point of discussion on social media due to its stock price movements in 2025. A recent dip followed by a strong rally has sparked debates about the sustainability of its upward trend. Some users see the fluctuations as a potential entry point, while others express caution.

Revenue Guidance and Drug Sales: The conversation has also centered on Amgen’s updated 2025 revenue guidance, driven by robust sales of key drugs like Repatha and Imdelltra. Social media buzz highlights optimism around these developments, alongside news of a dividend hike. There’s also chatter about a recent credit rating upgrade, adding to the positive momentum.

Drug Pricing Deal: A reported drug pricing deal linked to political developments has caught attention on social media platforms. Users are split on how this might impact Amgen’s long-term profitability and stock trajectory. The mix of speculation and analysis keeps the dialogue engaging and dynamic.

Note: This discussion summary was generated from an AI condensation of post data.

Amgen Inc. Insider Trading Activity

Amgen Inc. insiders have traded $AMGN stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $AMGN stock by insiders over the last 6 months:

• MURDO GORDON (EVP, Global Commercial Ops) sold 6,879 shares for an estimated $2,317,071
• NANCY A. GRYGIEL (SVP & CCO) has made 0 purchases and 3 sales selling 4,406 shares for an estimated $1,434,946.
• RACHNA KHOSLA (SVP, Business Development) sold 890 shares for an estimated $299,255

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Amgen Inc. Revenue

Amgen Inc. had revenues of $9.6B in Q3 2025. This is an increase of 12.4% from the same period in the prior year.

You can track AMGN financials on Quiver Quantitative's AMGN stock page.

Amgen Inc. Congressional Stock Trading

Members of Congress have traded $AMGN stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $AMGN stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/03.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 10/24, 09/11 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/25.
• SENATOR SHELDON WHITEHOUSE sold up to $15,000 on 09/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Amgen Inc. Hedge Fund Activity

We have seen 1,250 institutional investors add shares of Amgen Inc. stock to their portfolio, and 1,443 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,816,157 shares (+72.2%) to their portfolio in Q3 2025, for an estimated $1,076,919,505
• CAPITAL WORLD INVESTORS added 1,935,876 shares (+11.5%) to their portfolio in Q3 2025, for an estimated $546,304,207
• PRIMECAP MANAGEMENT CO/CA/ removed 924,100 shares (-8.7%) from their portfolio in Q3 2025, for an estimated $260,781,020
• NATIONAL BANK OF CANADA /FI/ added 866,166 shares (+240.5%) to their portfolio in Q3 2025, for an estimated $244,432,045
• MONTRUSCO BOLTON INVESTMENTS INC. removed 689,602 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $192,543,774
• CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 656,935 shares (+5.1%) to their portfolio in Q3 2025, for an estimated $185,387,057
• PERRITT CAPITAL MANAGEMENT INC removed 599,055 shares (-99.6%) from their portfolio in Q3 2025, for an estimated $169,053,321

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Amgen Inc. Analyst Ratings

Wall Street analysts have issued reports on $AMGN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• BMO Capital issued a "Outperform" rating on 12/03/2025
• Piper Sandler issued a "Overweight" rating on 11/14/2025
• B of A Securities issued a "Underperform" rating on 09/26/2025

To track analyst ratings and price targets for Amgen Inc., check out Quiver Quantitative's $AMGN forecast page.

Amgen Inc. Price Targets

Multiple analysts have issued price targets for $AMGN recently. We have seen 9 analysts offer price targets for $AMGN in the last 6 months, with a median target of $317.0.

Here are some recent targets:

• Terence Flynn from Morgan Stanley set a target price of $304.0 on 12/12/2025
• Mohit Bansal from Wells Fargo set a target price of $325.0 on 12/10/2025
• Evan David Seigerman from BMO Capital set a target price of $372.0 on 12/03/2025
• Gregory Renza from Truist Securities set a target price of $318.0 on 11/24/2025
• David Amsellem from Piper Sandler set a target price of $381.0 on 11/14/2025
• Carter Gould from Cantor Fitzgerald set a target price of $315.0 on 11/06/2025
• Tim Anderson from B of A Securities set a target price of $272.0 on 09/26/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$OPEN stock fell 6% this week, according to our price data from Polygon.

It has been the 47th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $OPEN (you can track the company live on Quiver's $OPEN stock page):

$OPEN Insider Trading Activity

$OPEN insiders have traded $OPEN stock on the open market 9 times in the past 6 months. Of those trades, 5 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $OPEN stock by insiders over the last 6 months:

• ERIC CHUNG-WEI WU has made 2 purchases buying 751,879 shares for an estimated $4,999,995 and 0 sales.
• KASRA NEJATIAN (Chief Executive Officer) purchased 125,000 shares for an estimated $1,004,562
• CHRISTINA SCHWARTZ (See Remarks) sold 73,951 shares for an estimated $583,961
• SHRISHA RADHAKRISHNA (President) has made 2 purchases buying 30,000 shares for an estimated $128,339 and 0 sales.
• SYDNEY SCHAUB (Chief Legal Officer) has made 0 purchases and 3 sales selling 47,361 shares for an estimated $122,477.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$OPEN Hedge Fund Activity

We have seen 212 institutional investors add shares of $OPEN stock to their portfolio, and 195 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JANE STREET GROUP, LLC added 23,861,727 shares (+1184.0%) to their portfolio in Q3 2025, for an estimated $190,177,964
• RENAISSANCE TECHNOLOGIES LLC added 17,272,580 shares (+195.6%) to their portfolio in Q3 2025, for an estimated $137,662,462
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 15,838,339 shares (-96.8%) from their portfolio in Q3 2025, for an estimated $126,231,561
• TWO SIGMA ADVISERS, LP removed 13,030,800 shares (-99.6%) from their portfolio in Q3 2025, for an estimated $103,855,476
• QUBE RESEARCH & TECHNOLOGIES LTD removed 12,540,603 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $99,948,605
• AMERICAN CENTURY COMPANIES INC added 11,007,457 shares (+inf%) to their portfolio in Q3 2025, for an estimated $87,729,432
• WEISS ASSET MANAGEMENT LP removed 9,606,779 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $76,566,028

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$OPEN Congressional Stock Trading

Members of Congress have traded $OPEN stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $OPEN stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 09/19, 07/21 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$OPEN Analyst Ratings

Wall Street analysts have issued reports on $OPEN in the last several months. We have seen 0 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Sell" rating on 11/12/2025
• Keefe, Bruyette & Woods issued a "Underperform" rating on 11/10/2025
• Zelman & Assoc issued a "Underperform" rating on 08/07/2025

To track analyst ratings and price targets for $OPEN, check out Quiver Quantitative's $OPEN forecast page.

$OPEN Price Targets

Multiple analysts have issued price targets for $OPEN recently. We have seen 4 analysts offer price targets for $OPEN in the last 6 months, with a median target of $1.5.

Here are some recent targets:

• Ygal Arounian from Citigroup set a target price of $1.4 on 11/12/2025
• Ryan Tomasello from Keefe, Bruyette & Woods set a target price of $2.0 on 11/10/2025
• An analyst from Zelman & Assoc set a target price of $1.0 on 08/07/2025
• Lloyd Walmsley from UBS set a target price of $1.6 on 08/06/2025

You can track data on $OPEN on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$RIVN stock fell 7% this week, according to our price data from Polygon.

It has been the 50th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $RIVN (you can track the company live on Quiver's $RIVN stock page):

$RIVN Insider Trading Activity

$RIVN insiders have traded $RIVN stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $RIVN stock by insiders over the last 6 months:

• ROBERT J SCARINGE (Chief Executive Officer) has made 0 purchases and 5 sales selling 122,150 shares for an estimated $1,927,132.
• CLAIRE MCDONOUGH (Chief Financial Officer) has made 0 purchases and 3 sales selling 36,496 shares for an estimated $597,164.
• PETER KRAWIEC sold 3,655 shares for an estimated $71,076

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RIVN Hedge Fund Activity

We have seen 335 institutional investors add shares of $RIVN stock to their portfolio, and 371 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 11,966,036 shares (-79.2%) from their portfolio in Q3 2025, for an estimated $175,661,408
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 10,507,799 shares (+65.4%) to their portfolio in Q3 2025, for an estimated $154,254,489
• RENAISSANCE TECHNOLOGIES LLC added 10,393,910 shares (+522.0%) to their portfolio in Q3 2025, for an estimated $152,582,598
• JANE STREET GROUP, LLC added 7,074,233 shares (+8348.9%) to their portfolio in Q3 2025, for an estimated $103,849,740
• CITIGROUP INC added 4,954,071 shares (+138.1%) to their portfolio in Q3 2025, for an estimated $72,725,762
• BANK OF AMERICA CORP /DE/ removed 4,606,062 shares (-25.9%) from their portfolio in Q3 2025, for an estimated $67,616,990
• MORGAN STANLEY removed 3,618,449 shares (-30.3%) from their portfolio in Q3 2025, for an estimated $53,118,831

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$RIVN Analyst Ratings

Wall Street analysts have issued reports on $RIVN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Baird issued a "Outperform" rating on 12/18/2025
• Stifel issued a "Buy" rating on 11/17/2025
• Tigress Financial issued a "Buy" rating on 11/14/2025
• Mizuho issued a "Underperform" rating on 10/20/2025
• Needham issued a "Buy" rating on 08/06/2025
• Wedbush issued a "Outperform" rating on 08/06/2025
• JP Morgan issued a "Underweight" rating on 08/06/2025

To track analyst ratings and price targets for $RIVN, check out Quiver Quantitative's $RIVN forecast page.

$RIVN Price Targets

Multiple analysts have issued price targets for $RIVN recently. We have seen 13 analysts offer price targets for $RIVN in the last 6 months, with a median target of $16.0.

Here are some recent targets:

• Dan Ives from Wedbush set a target price of $25.0 on 12/19/2025
• George Gianarikas from Baird set a target price of $25.0 on 12/18/2025
• Mark Delaney from Goldman Sachs set a target price of $16.0 on 12/12/2025
• Chris Pierce from Needham set a target price of $23.0 on 12/12/2025
• Adam Jonas from Morgan Stanley set a target price of $12.0 on 12/08/2025
• Stephen Gengaro from Stifel set a target price of $17.0 on 11/17/2025
• Ivan Feinseth from Tigress Financial set a target price of $25.0 on 11/14/2025

You can track data on $RIVN on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$HOOD stock fell 3% this week, according to our price data from Polygon.

It has been the 49th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $HOOD (you can track the company live on Quiver's $HOOD stock page):

$HOOD Insider Trading Activity

$HOOD insiders have traded $HOOD stock on the open market 131 times in the past 6 months. Of those trades, 0 have been purchases and 131 have been sales.

Here’s a breakdown of recent trading of $HOOD stock by insiders over the last 6 months:

• VLADIMIR TENEV (Chief Executive Officer) has made 0 purchases and 15 sales selling 5,525,932 shares for an estimated $629,647,775.
• BAIJU BHATT has made 0 purchases and 22 sales selling 5,000,629 shares for an estimated $571,512,350.
• MEYER MALKA has made 0 purchases and 3 sales selling 1,173,808 shares for an estimated $121,937,352.
• JASON WARNICK (Chief Financial Officer) has made 0 purchases and 6 sales selling 575,000 shares for an estimated $66,700,260.
• DANIEL MARTIN JR GALLAGHER (Chief Legal Officer) has made 0 purchases and 33 sales selling 530,000 shares for an estimated $60,378,636.
• STEVEN M. QUIRK (Chief Brokerage Officer) has made 0 purchases and 20 sales selling 198,536 shares for an estimated $23,616,758.
• JEFFREY TSVI PINNER (Chief Technology Officer) has made 0 purchases and 28 sales selling 46,914 shares for an estimated $5,695,857.
• JONATHAN RUBINSTEIN has made 0 purchases and 4 sales selling 42,430 shares for an estimated $5,611,794.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$HOOD Hedge Fund Activity

We have seen 830 institutional investors add shares of $HOOD stock to their portfolio, and 543 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 18,824,923 shares (+24.9%) to their portfolio in Q3 2025, for an estimated $2,695,352,475
• STATE STREET CORP added 16,375,734 shares (+103.2%) to their portfolio in Q3 2025, for an estimated $2,344,677,594
• BLACKROCK, INC. added 16,213,055 shares (+37.5%) to their portfolio in Q3 2025, for an estimated $2,321,385,214
• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 10,110,525 shares (-99.5%) from their portfolio in Q3 2025, for an estimated $1,447,624,969
• RENAISSANCE TECHNOLOGIES LLC removed 9,513,384 shares (-82.6%) from their portfolio in Q3 2025, for an estimated $1,362,126,321
• GEODE CAPITAL MANAGEMENT, LLC added 7,638,484 shares (+58.0%) to their portfolio in Q3 2025, for an estimated $1,093,678,139
• FMR LLC removed 7,579,476 shares (-19.5%) from their portfolio in Q3 2025, for an estimated $1,085,229,373

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$HOOD Congressional Stock Trading

Members of Congress have traded $HOOD stock 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $HOOD stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 3 purchases worth up to $45,000 on 11/18, 10/17, 07/09 and 0 sales.
• REPRESENTATIVE JONATHAN L. JACKSON has traded it 3 times. They made 3 purchases worth up to $115,000 on 11/06, 10/08, 09/05 and 0 sales.
• REPRESENTATIVE CLEO FIELDS has traded it 2 times. They made 2 purchases worth up to $100,000 on 07/21, 07/17 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$HOOD Analyst Ratings

Wall Street analysts have issued reports on $HOOD in the last several months. We have seen 12 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Truist Securities issued a "Buy" rating on 12/17/2025
• B of A Securities issued a "Buy" rating on 12/10/2025
• Citizens issued a "Market Outperform" rating on 11/07/2025
• Mizuho issued a "Outperform" rating on 11/06/2025
• CICC issued a "Outperform" rating on 10/27/2025
• JMP Securities issued a "Market Outperform" rating on 10/09/2025
• Goldman Sachs issued a "Buy" rating on 09/30/2025

To track analyst ratings and price targets for $HOOD, check out Quiver Quantitative's $HOOD forecast page.

$HOOD Price Targets

Multiple analysts have issued price targets for $HOOD recently. We have seen 15 analysts offer price targets for $HOOD in the last 6 months, with a median target of $154.0.

Here are some recent targets:

• Michael Cyprys from Morgan Stanley set a target price of $147.0 on 12/22/2025
• David Smith from Truist Securities set a target price of $155.0 on 12/17/2025
• Benjamin Budish from Barclays set a target price of $171.0 on 12/12/2025
• Brett Knoblauch from Cantor Fitzgerald set a target price of $152.0 on 12/11/2025
• Craig Siegenthaler from B of A Securities set a target price of $154.0 on 12/10/2025
• John Todaro from Needham set a target price of $145.0 on 12/05/2025
• Devin Ryan from Citizens set a target price of $180.0 on 11/07/2025

You can track data on $HOOD on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$TEM stock fell 3% this week, according to our price data from Polygon.

It has been the 4th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $TEM (you can track the company live on Quiver's $TEM stock page):

$TEM Insider Trading Activity

$TEM insiders have traded $TEM stock on the open market 121 times in the past 6 months. Of those trades, 0 have been purchases and 121 have been sales.

Here’s a breakdown of recent trading of $TEM stock by insiders over the last 6 months:

• ERIC P LEFKOFSKY (CEO and Chairman) has made 0 purchases and 66 sales selling 1,696,787 shares for an estimated $127,005,580.
• THEODORE LEONSIS has made 0 purchases and 2 sales selling 64,000 shares for an estimated $4,592,200.
• RYAN FUKUSHIMA (Chief Operating Officer) has made 0 purchases and 20 sales selling 57,559 shares for an estimated $4,308,740.
• JAMES WILLIAM ROGERS (Chief Financial Officer) has made 0 purchases and 7 sales selling 34,751 shares for an estimated $2,499,084.
• ANDREW POLOVIN (EVP and General Counsel) has made 0 purchases and 9 sales selling 29,864 shares for an estimated $2,144,365.
• ERIK PHELPS (EVP & Chief Admin & Legal Off) has made 0 purchases and 5 sales selling 8,499 shares for an estimated $592,859.
• WAYNE A.I. FREDERICK sold 3,675 shares for an estimated $283,820
• RYAN M BARTOLUCCI (Chief Accounting Officer) has made 0 purchases and 4 sales selling 3,738 shares for an estimated $262,337.
• JENNIFER A DOUDNA has made 0 purchases and 3 sales selling 3,227 shares for an estimated $227,759.
• DAVID R EPSTEIN has made 0 purchases and 4 sales selling 1,240 shares for an estimated $91,006.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$TEM Hedge Fund Activity

We have seen 253 institutional investors add shares of $TEM stock to their portfolio, and 169 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GOLDMAN SACHS GROUP INC removed 4,030,697 shares (-94.7%) from their portfolio in Q3 2025, for an estimated $325,317,554
• NEA MANAGEMENT COMPANY, LLC removed 2,615,979 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $166,219,305
• BLACKROCK, INC. added 2,597,838 shares (+62.8%) to their portfolio in Q3 2025, for an estimated $209,671,504
• BAILLIE GIFFORD & CO removed 2,401,588 shares (-19.9%) from their portfolio in Q3 2025, for an estimated $193,832,167
• VANGUARD GROUP INC added 1,706,837 shares (+22.1%) to their portfolio in Q3 2025, for an estimated $137,758,814
• D. E. SHAW & CO., INC. added 1,605,757 shares (+380.8%) to their portfolio in Q3 2025, for an estimated $129,600,647
• BANK OF AMERICA CORP /DE/ added 1,277,244 shares (+112.9%) to their portfolio in Q3 2025, for an estimated $103,086,363

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$TEM Government Contracts

We have seen $18,460,020 of award payments to $TEM over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• ADAPT CRO SUPPORT SERVICES SOLICITATION: $12,741,975
• TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES: $5,718,045

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$TEM Analyst Ratings

Wall Street analysts have issued reports on $TEM in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Canaccord Genuity issued a "Buy" rating on 12/22/2025
• BTIG issued a "Buy" rating on 11/25/2025
• Morgan Stanley issued a "Overweight" rating on 11/11/2025
• HC Wainwright & Co. issued a "Buy" rating on 11/07/2025
• Guggenheim issued a "Buy" rating on 09/26/2025

To track analyst ratings and price targets for $TEM, check out Quiver Quantitative's $TEM forecast page.

$TEM Price Targets

Multiple analysts have issued price targets for $TEM recently. We have seen 8 analysts offer price targets for $TEM in the last 6 months, with a median target of $87.0.

Here are some recent targets:

• Kyle Mikson from Canaccord Genuity set a target price of $80.0 on 12/22/2025
• Casey Woodring from JP Morgan set a target price of $80.0 on 12/15/2025
• Tejas Savant from Morgan Stanley set a target price of $85.0 on 12/02/2025
• Mark Massaro from BTIG set a target price of $105.0 on 11/25/2025
• David Westenberg from Piper Sandler set a target price of $80.0 on 11/11/2025
• Yi Chen from HC Wainwright & Co. set a target price of $89.0 on 11/07/2025
• Ryan MacDonald from Needham set a target price of $100.0 on 11/05/2025

You can track data on $TEM on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$MSTR stock fell 4% this week, according to our price data from Polygon.

It has been the 13th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $MSTR (you can track the company live on Quiver's $MSTR stock page):

$MSTR Insider Trading Activity

$MSTR insiders have traded $MSTR stock on the open market 89 times in the past 6 months. Of those trades, 15 have been purchases and 74 have been sales.

Here’s a breakdown of recent trading of $MSTR stock by insiders over the last 6 months:

• WEI-MING SHAO (EVP & General Counsel) has made 2 purchases buying 15,000 shares for an estimated $1,436,450 and 68 sales selling 142,402 shares for an estimated $51,370,057.
• PETER L JR BRIGER purchased 220,000 shares for an estimated $19,800,000
• JEANINE MONTGOMERY (VP & CAO) has made 1 purchase buying 5,000 shares for an estimated $450,000 and 2 sales selling 43,793 shares for an estimated $18,845,092.
• ANDREW KANG (EVP & CFO) has made 1 purchase buying 2,800 shares for an estimated $252,000 and 4 sales selling 25,000 shares for an estimated $9,820,750.
• JARROD M PATTEN has made 3 purchases buying 29,335 shares for an estimated $2,816,253 and 0 sales.
• GREGG WINIARSKI purchased 10,000 shares for an estimated $976,520
• PHONG LE (President & CEO) has made 4 purchases buying 5,619 shares for an estimated $506,308 and 0 sales.
• JANE A DIETZE has made 2 purchases buying 2,600 shares for an estimated $239,808 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$MSTR Hedge Fund Activity

We have seen 630 institutional investors add shares of $MSTR stock to their portfolio, and 558 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CLEAR STREET LLC added 5,971,971 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,414,049,837
• CLEAR STREET DERIVATIVES LLC removed 5,283,815 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,135,876,537
• CAPULA MANAGEMENT LTD added 1,755,481 shares (+309608.6%) to their portfolio in Q3 2025, for an estimated $565,633,533
• NATIONAL BANK OF CANADA /FI/ added 1,476,858 shares (+260.0%) to their portfolio in Q3 2025, for an estimated $475,858,416
• ROYAL BANK OF CANADA added 1,376,824 shares (+729.8%) to their portfolio in Q3 2025, for an estimated $443,626,461
• VANGUARD GROUP INC added 1,344,519 shares (+7.3%) to their portfolio in Q3 2025, for an estimated $433,217,466
• GOLDMAN SACHS GROUP INC added 1,300,403 shares (+164.2%) to their portfolio in Q3 2025, for an estimated $419,002,850

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$MSTR Government Contracts

We have seen $29,200 of award payments to $MSTR over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• MICROSTRATEGY TECHNICAL SUPPORT STANDARD RENEWAL - FY25 HHS PROGRAM PERFORMANCE TRACKING SYSTEM: $29,200

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$MSTR Analyst Ratings

Wall Street analysts have issued reports on $MSTR in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 12/22/2025
• HC Wainwright & Co. issued a "Buy" rating on 11/03/2025
• Canaccord Genuity issued a "Buy" rating on 11/03/2025
• BTIG issued a "Buy" rating on 10/31/2025
• TD Cowen issued a "Buy" rating on 10/31/2025
• Mizuho issued a "Outperform" rating on 08/11/2025
• Benchmark issued a "Buy" rating on 08/01/2025

To track analyst ratings and price targets for $MSTR, check out Quiver Quantitative's $MSTR forecast page.

$MSTR Price Targets

Multiple analysts have issued price targets for $MSTR recently. We have seen 11 analysts offer price targets for $MSTR in the last 6 months, with a median target of $475.0.

Here are some recent targets:

• Peter Christiansen from Citigroup set a target price of $325.0 on 12/22/2025
• Gautam Chhugani from Bernstein set a target price of $450.0 on 12/08/2025
• Mike Colonnese from HC Wainwright & Co. set a target price of $475.0 on 11/03/2025
• Joseph Vafi from Canaccord Genuity set a target price of $474.0 on 11/03/2025
• Andrew Harte from BTIG set a target price of $630.0 on 10/31/2025
• Lance Vitanza from TD Cowen set a target price of $535.0 on 10/31/2025
• Brett Knoblauch from Cantor Fitzgerald set a target price of $560.0 on 10/31/2025

You can track data on $MSTR on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$CRWV stock fell 8% this week, according to our price data from Polygon.

It has been the 16th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $CRWV (you can track the company live on Quiver's $CRWV stock page):

$CRWV Insider Trading Activity

$CRWV insiders have traded $CRWV stock on the open market 1852 times in the past 6 months. Of those trades, 0 have been purchases and 1852 have been sales.

Here’s a breakdown of recent trading of $CRWV stock by insiders over the last 6 months:

• FINANCIAL LLC MAGNETAR has made 0 purchases and 1228 sales selling 27,626,854 shares for an estimated $3,608,934,556.
• BRANNIN MCBEE (Chief Development Officer) has made 0 purchases and 250 sales selling 4,724,583 shares for an estimated $487,605,082.
• JACK D COGEN has made 0 purchases and 14 sales selling 5,112,004 shares for an estimated $477,148,645.
• BRIAN M VENTURO (Chief Strategy Officer) has made 0 purchases and 132 sales selling 2,729,493 shares for an estimated $288,739,176.
• MICHAEL N INTRATOR (CEO and President) has made 0 purchases and 157 sales selling 882,453 shares for an estimated $95,803,536.
• KRISTEN J MCVEETY (GC and Secretary) has made 0 purchases and 28 sales selling 413,435 shares for an estimated $42,284,670.
• NITIN AGRAWAL (Chief Financial Officer) has made 0 purchases and 28 sales selling 223,439 shares for an estimated $21,433,219.
• CHEN GOLDBERG (SVP of Engineering) has made 0 purchases and 15 sales selling 89,214 shares for an estimated $8,761,311.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CRWV Hedge Fund Activity

We have seen 465 institutional investors add shares of $CRWV stock to their portfolio, and 119 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• INFINITUM ASSET MANAGEMENT, LLC removed 18,540,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,023,132,400
• PROFICIO CAPITAL PARTNERS LLC added 17,847,760 shares (+446194.0%) to their portfolio in Q3 2025, for an estimated $2,442,465,956
• MAGNETAR FINANCIAL LLC removed 13,834,923 shares (-14.4%) from their portfolio in Q3 2025, for an estimated $1,893,309,212
• COATUE MANAGEMENT LLC removed 11,072,958 shares (-62.2%) from their portfolio in Q3 2025, for an estimated $1,515,334,302
• JANE STREET GROUP, LLC added 7,253,308 shares (+143.8%) to their portfolio in Q3 2025, for an estimated $992,615,199
• INVESTMENT MANAGEMENT CORP OF ONTARIO removed 7,000,000 shares (-80.6%) from their portfolio in Q3 2025, for an estimated $957,950,000
• PEAK6 LLC removed 6,629,141 shares (-76.3%) from their portfolio in Q3 2025, for an estimated $907,197,945

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CRWV Congressional Stock Trading

Members of Congress have traded $CRWV stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CRWV stock by members of Congress over the last 6 months:

• REPRESENTATIVE CLEO FIELDS has traded it 3 times. They made 2 purchases worth up to $30,000 on 10/10, 10/09 and 1 sale worth up to $50,000 on 12/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CRWV Analyst Ratings

Wall Street analysts have issued reports on $CRWV in the last several months. We have seen 14 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Roth Capital issued a "Buy" rating on 12/05/2025
• Freedom Capital Markets issued a "Buy" rating on 12/05/2025
• Compass Point issued a "Buy" rating on 11/13/2025
• HC Wainwright & Co. issued a "Buy" rating on 11/12/2025
• Wells Fargo issued a "Overweight" rating on 11/12/2025
• DA Davidson issued a "Underperform" rating on 11/11/2025
• Jefferies issued a "Buy" rating on 11/11/2025

To track analyst ratings and price targets for $CRWV, check out Quiver Quantitative's $CRWV forecast page.

$CRWV Price Targets

Multiple analysts have issued price targets for $CRWV recently. We have seen 28 analysts offer price targets for $CRWV in the last 6 months, with a median target of $125.0.

Here are some recent targets:

• Tyler Radke from Citigroup set a target price of $135.0 on 12/19/2025
• Rohit Kulkarni from Roth Capital set a target price of $110.0 on 12/05/2025
• Paul Meeks from Freedom Capital Markets set a target price of $100.0 on 12/05/2025
• Kash Rangan from Goldman Sachs set a target price of $105.0 on 11/17/2025
• Michael Donovan from Compass Point set a target price of $150.0 on 11/13/2025
• Raimo Lenschow from Barclays set a target price of $120.0 on 11/12/2025
• Michael Turrin from Wells Fargo set a target price of $150.0 on 11/12/2025

You can track data on $CRWV on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$GME stock fell 7% this week, according to our price data from Polygon.

It has been the 22nd most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $GME (you can track the company live on Quiver's $GME stock page):

$GME Insider Trading Activity

$GME insiders have traded $GME stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $GME stock by insiders over the last 6 months:

• MARK HAYMOND ROBINSON (General Counsel and Secretary) has made 0 purchases and 4 sales selling 16,803 shares for an estimated $421,137.
• DANIEL WILLIAM MOORE (PFO and PAO) has made 0 purchases and 3 sales selling 8,060 shares for an estimated $215,626.
• JAMES GRUBE purchased 5,575 shares for an estimated $132,183

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$GME Hedge Fund Activity

We have seen 169 institutional investors add shares of $GME stock to their portfolio, and 181 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CITADEL ADVISORS LLC removed 4,820,819 shares (-97.5%) from their portfolio in Q3 2025, for an estimated $131,511,942
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 3,512,016 shares (+73.7%) to their portfolio in Q3 2025, for an estimated $95,807,796
• NORGES BANK added 3,080,586 shares (+4799.3%) to their portfolio in Q2 2025, for an estimated $75,135,492
• JANE STREET GROUP, LLC added 3,025,789 shares (+305.0%) to their portfolio in Q3 2025, for an estimated $82,543,523
• CLEAR STREET LLC added 2,354,779 shares (+inf%) to their portfolio in Q2 2025, for an estimated $57,433,059
• UBS GROUP AG removed 2,326,213 shares (-50.1%) from their portfolio in Q3 2025, for an estimated $63,459,090
• ALYESKA INVESTMENT GROUP, L.P. removed 2,128,821 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $58,074,236

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

You can track data on $GME on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$PLTR stock fell 3% this week, according to our price data from Polygon.

It has been the 11th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $PLTR (you can track the company live on Quiver's $PLTR stock page):

$PLTR Insider Trading Activity

$PLTR insiders have traded $PLTR stock on the open market 337 times in the past 6 months. Of those trades, 0 have been purchases and 337 have been sales.

Here’s a breakdown of recent trading of $PLTR stock by insiders over the last 6 months:

• ALEXANDER C. KARP (See Remarks) has made 0 purchases and 40 sales selling 813,961 shares for an estimated $128,780,320.
• SHYAM SANKAR (See Remarks) has made 0 purchases and 61 sales selling 744,737 shares for an estimated $115,236,197.
• STEPHEN ANDREW COHEN (See Remarks) has made 0 purchases and 40 sales selling 699,655 shares for an estimated $110,692,932.
• RYAN D. TAYLOR (See Remarks) has made 0 purchases and 52 sales selling 209,016 shares for an estimated $32,689,604.
• ALEXANDER D. MOORE has made 0 purchases and 39 sales selling 120,000 shares for an estimated $19,958,898.
• DAVID A. GLAZER (See Remarks) has made 0 purchases and 49 sales selling 125,210 shares for an estimated $19,755,844.
• LAUREN ELAINA FRIEDMAN STAT has made 0 purchases and 7 sales selling 31,600 shares for an estimated $5,344,066.
• JEFFREY BUCKLEY (See Remarks) has made 0 purchases and 42 sales selling 9,085 shares for an estimated $1,434,669.
• ERIC H. WOERSCHING has made 0 purchases and 7 sales selling 10,214 shares for an estimated $1,337,545.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PLTR Hedge Fund Activity

We have seen 1,603 institutional investors add shares of $PLTR stock to their portfolio, and 1,170 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 18,622,083 shares (-99.8%) from their portfolio in Q3 2025, for an estimated $3,397,040,380
• JPMORGAN CHASE & CO added 18,587,777 shares (+115.6%) to their portfolio in Q3 2025, for an estimated $3,390,782,280
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 16,020,379 shares (+107.0%) to their portfolio in Q3 2025, for an estimated $2,922,437,537
• BLACKROCK, INC. added 11,275,223 shares (+6.4%) to their portfolio in Q3 2025, for an estimated $2,056,826,179
• VANGUARD GROUP INC added 8,168,604 shares (+4.0%) to their portfolio in Q3 2025, for an estimated $1,490,116,741
• STATE STREET CORP added 6,777,771 shares (+7.2%) to their portfolio in Q3 2025, for an estimated $1,236,400,985
• NORGES BANK added 6,277,645 shares (+34.9%) to their portfolio in Q2 2025, for an estimated $855,768,566

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$PLTR Government Contracts

We have seen $691,617,262 of award payments to $PLTR over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• TASK ORDER #1 FOR MAVEN SMART SYSTEM - USER INTERFACE/USER EXPERIENCE (UI/UX) PROTOTYPE: $114,422,914
• INVESTIGATIVE CASE MANAGEMENT (ICM) OPERATIONS AND MAINTENANCE (O&M) SUPPORT SERVICES AND CUSTOM ENHANCEMENTS: $81,116,690
• SOFTWARE AS A SERVICE (SAAS) MODEL OF ARMY VANTAGE ON BEHALF OF PEO EIS, PDM ADP. ARMY VANTAGE IS THE ARMY'...: $68,048,339
• TASK ORDER OFF A COMMERCIAL SOLUTIONS OPENING (CSO) FOR RESEARCH AND DEVELOPMENT FOR MAVEN SMART SYSTEM (MS...: $37,874,170
• DATA SOFTWARE SERVICES (DSS) MULTIPLE AWARD IDIQ CONTRACT DELIVERY ORDER FOR HAF DATA PLATFORM REQUIREMENTS.: $33,551,421

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$PLTR Congressional Stock Trading

Members of Congress have traded $PLTR stock 13 times in the past 6 months. Of those trades, 10 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $PLTR stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 3 purchases worth up to $45,000 on 11/18, 11/07, 10/09 and 0 sales.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
• REPRESENTATIVE CLEO FIELDS has traded it 5 times. They made 5 purchases worth up to $600,000 on 10/10, 08/13, 07/28, 07/18, 06/30 and 0 sales.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 07/15.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 06/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$PLTR Analyst Ratings

Wall Street analysts have issued reports on $PLTR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• RBC Capital issued a "Underperform" rating on 11/04/2025
• Piper Sandler issued a "Overweight" rating on 11/04/2025
• B of A Securities issued a "Buy" rating on 11/04/2025
• Loop Capital issued a "Buy" rating on 07/30/2025

To track analyst ratings and price targets for $PLTR, check out Quiver Quantitative's $PLTR forecast page.

$PLTR Price Targets

Multiple analysts have issued price targets for $PLTR recently. We have seen 15 analysts offer price targets for $PLTR in the last 6 months, with a median target of $200.0.

Here are some recent targets:

• Mariana Perez Mora from B of A Securities set a target price of $255.0 on 11/04/2025
• Gil Luria from DA Davidson set a target price of $215.0 on 11/04/2025
• Rishi Jaluria from RBC Capital set a target price of $50.0 on 11/04/2025
• William Power from Baird set a target price of $200.0 on 11/04/2025
• Gabriela Borges from Goldman Sachs set a target price of $188.0 on 11/04/2025
• Sanjit Singh from Morgan Stanley set a target price of $205.0 on 11/04/2025
• Thomas Blakey from Cantor Fitzgerald set a target price of $198.0 on 11/04/2025

You can track data on $PLTR on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$HIMS stock fell 4% this week, according to our price data from Polygon.

It has been the 14th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $HIMS (you can track the company live on Quiver's $HIMS stock page):

$HIMS Insider Trading Activity

$HIMS insiders have traded $HIMS stock on the open market 64 times in the past 6 months. Of those trades, 0 have been purchases and 64 have been sales.

Here’s a breakdown of recent trading of $HIMS stock by insiders over the last 6 months:

• ANDREW DUDUM (Chief Executive Officer) has made 0 purchases and 24 sales selling 1,252,093 shares for an estimated $62,715,056.
• OLUYEMI OKUPE (Chief Financial Officer) has made 0 purchases and 12 sales selling 369,372 shares for an estimated $19,669,723.
• MICHAEL CHI (Chief Operating Officer) has made 0 purchases and 10 sales selling 77,349 shares for an estimated $4,288,956.
• PATRICK HARRISON CARROLL (Chief Medical Officer) has made 0 purchases and 3 sales selling 80,042 shares for an estimated $4,088,809.
• SOLEIL BOUGHTON (Chief Legal Officer) has made 0 purchases and 11 sales selling 28,675 shares for an estimated $1,419,687.
• IRENE BECKLUND (PAO) has made 0 purchases and 2 sales selling 16,821 shares for an estimated $733,472.
• DEBORAH M. AUTOR (Chief Policy Officer) sold 7,054 shares for an estimated $258,952
• GARCIA ANDREA G PEREZ sold 2,500 shares for an estimated $97,925

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$HIMS Hedge Fund Activity

We have seen 303 institutional investors add shares of $HIMS stock to their portfolio, and 288 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO added 15,045,710 shares (+549.0%) to their portfolio in Q3 2025, for an estimated $853,392,671
• SRS INVESTMENT MANAGEMENT, LLC removed 4,000,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $226,880,000
• TIDAL INVESTMENTS LLC added 2,707,111 shares (+1779.6%) to their portfolio in Q3 2025, for an estimated $153,547,335
• FARALLON CAPITAL MANAGEMENT LLC added 2,533,271 shares (+30.8%) to their portfolio in Q3 2025, for an estimated $143,687,131
• PRICE T ROWE ASSOCIATES INC /MD/ added 2,504,252 shares (+444.1%) to their portfolio in Q3 2025, for an estimated $142,041,173
• RENAISSANCE TECHNOLOGIES LLC added 2,227,400 shares (+32.4%) to their portfolio in Q3 2025, for an estimated $126,338,128
• D. E. SHAW & CO., INC. removed 1,886,971 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $107,028,995

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$HIMS Congressional Stock Trading

Members of Congress have traded $HIMS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $HIMS stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 08/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$HIMS Analyst Ratings

Wall Street analysts have issued reports on $HIMS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 11/04/2025
• B of A Securities issued a "Underperform" rating on 11/04/2025
• Canaccord Genuity issued a "Buy" rating on 09/12/2025

To track analyst ratings and price targets for $HIMS, check out Quiver Quantitative's $HIMS forecast page.

$HIMS Price Targets

Multiple analysts have issued price targets for $HIMS recently. We have seen 5 analysts offer price targets for $HIMS in the last 6 months, with a median target of $48.0.

Here are some recent targets:

• Glen Santangelo from Barclays set a target price of $48.0 on 12/09/2025
• David Larsen from BTIG set a target price of $85.0 on 11/04/2025
• Allen Lutz from B of A Securities set a target price of $32.0 on 11/04/2025
• Maria Ripps from Canaccord Genuity set a target price of $68.0 on 09/12/2025
• Jailendra Singh from Truist Securities set a target price of $37.0 on 08/18/2025

You can track data on $HIMS on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$BBAI stock fell 9% this week, according to our price data from Polygon.

It has been the 19th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $BBAI (you can track the company live on Quiver's $BBAI stock page):

$BBAI Insider Trading Activity

$BBAI insiders have traded $BBAI stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $BBAI stock by insiders over the last 6 months:

• DOROTHY D HAYES has made 0 purchases and 2 sales selling 52,000 shares for an estimated $308,770.
• SEAN RAYMOND RICKER (Chief Financial Officer) has made 0 purchases and 3 sales selling 16,980 shares for an estimated $99,388.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BBAI Hedge Fund Activity

We have seen 207 institutional investors add shares of $BBAI stock to their portfolio, and 127 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• AE INDUSTRIAL PARTNERS, LP removed 27,430,402 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $186,252,429
• VANGUARD GROUP INC added 6,790,890 shares (+32.6%) to their portfolio in Q3 2025, for an estimated $44,276,602
• JUMP FINANCIAL, LLC removed 5,509,104 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $35,919,358
• MAREX GROUP PLC added 5,033,668 shares (+2421.6%) to their portfolio in Q3 2025, for an estimated $32,819,515
• BLACKROCK, INC. added 3,619,539 shares (+18.0%) to their portfolio in Q3 2025, for an estimated $23,599,394
• RENAISSANCE TECHNOLOGIES LLC removed 3,257,500 shares (-58.7%) from their portfolio in Q3 2025, for an estimated $21,238,900
• TWO SIGMA INVESTMENTS, LP added 3,056,597 shares (+165.5%) to their portfolio in Q3 2025, for an estimated $19,929,012

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$BBAI Government Contracts

We have seen $3,538,284 of award payments to $BBAI over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• COMMERICAL SOLUTIONS OPENING (CSO) FROM TRADEWINDS SOLUTIONS MARKETPLACE FOR THE ORION DECISION SUPPORT PLA...: $2,845,394
• BUSINESS REQUIREMENT SUPPORT: $692,889

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$BBAI Congressional Stock Trading

Members of Congress have traded $BBAI stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BBAI stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN purchased up to $50,000 on 08/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BBAI Analyst Ratings

Wall Street analysts have issued reports on $BBAI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 08/12/2025

To track analyst ratings and price targets for $BBAI, check out Quiver Quantitative's $BBAI forecast page.

You can track data on $BBAI on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$CRCL stock fell 6% this week, according to our price data from Polygon.

It has been the 37th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $CRCL (you can track the company live on Quiver's $CRCL stock page):

$CRCL Insider Trading Activity

$CRCL insiders have traded $CRCL stock on the open market 49 times in the past 6 months. Of those trades, 0 have been purchases and 49 have been sales.

Here’s a breakdown of recent trading of $CRCL stock by insiders over the last 6 months:

• JEREMY ALLAIRE (Chairman and CEO) has made 0 purchases and 11 sales selling 373,438 shares for an estimated $46,876,237.
• RAJEEV V DATE has made 0 purchases and 15 sales selling 530,446 shares for an estimated $44,606,677.
• PATRICK SEAN NEVILLE has made 0 purchases and 4 sales selling 328,943 shares for an estimated $39,092,069.
• NIKHIL CHANDHOK (Chief Product & Tech. Officer) has made 0 purchases and 7 sales selling 170,000 shares for an estimated $15,861,753.
• JEREMY FOX-GEEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 73,830 shares for an estimated $8,309,405.
• HEATH TARBERT (President) has made 0 purchases and 3 sales selling 36,273 shares for an estimated $4,448,380.
• M MICHELE BURNS sold 29,946 shares for an estimated $3,805,387
• DANITA K OSTLING has made 0 purchases and 2 sales selling 3,952 shares for an estimated $389,371.
• TAMARA L SCHULZ (Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,836 shares for an estimated $184,254.
• CRAIG W. BRODERICK sold 1,035 shares for an estimated $131,522

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CRCL Hedge Fund Activity

We have seen 231 institutional investors add shares of $CRCL stock to their portfolio, and 107 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 2,458,044 shares (+356.2%) to their portfolio in Q3 2025, for an estimated $325,887,473
• VANGUARD GROUP INC added 2,126,072 shares (+61.6%) to their portfolio in Q3 2025, for an estimated $281,874,625
• ATLAS MERCHANT CAPITAL LLC added 1,687,376 shares (+inf%) to their portfolio in Q3 2025, for an estimated $223,712,310
• GENERAL CATALYST GROUP MANAGEMENT, LLC removed 1,119,728 shares (-5.6%) from their portfolio in Q3 2025, for an estimated $148,453,538
• BLACKROCK, INC. added 1,082,068 shares (+31.5%) to their portfolio in Q3 2025, for an estimated $143,460,575
• SUMITOMO MITSUI TRUST GROUP, INC. added 959,309 shares (+282.1%) to their portfolio in Q3 2025, for an estimated $127,185,187
• FMR LLC removed 787,509 shares (-5.7%) from their portfolio in Q3 2025, for an estimated $104,407,943

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CRCL Analyst Ratings

Wall Street analysts have issued reports on $CRCL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Overweight" rating on 11/13/2025
• Needham issued a "Buy" rating on 11/13/2025
• JP Morgan issued a "Overweight" rating on 11/13/2025
• Monness, Crespi, Hardt issued a "Buy" rating on 11/10/2025
• William Blair issued a "Outperform" rating on 10/14/2025
• Canaccord Genuity issued a "Buy" rating on 09/11/2025
• Compass Point issued a "Sell" rating on 07/22/2025

To track analyst ratings and price targets for $CRCL, check out Quiver Quantitative's $CRCL forecast page.

$CRCL Price Targets

Multiple analysts have issued price targets for $CRCL recently. We have seen 13 analysts offer price targets for $CRCL in the last 6 months, with a median target of $110.0.

Here are some recent targets:

• Mike Colonnese from HC Wainwright & Co. set a target price of $85.0 on 12/19/2025
• Daniel Krebs from Wolfe Research set a target price of $60.0 on 12/02/2025
• James Yaro from Goldman Sachs set a target price of $80.0 on 11/21/2025
• David Koning from Baird set a target price of $110.0 on 11/14/2025
• Dan Dolev from Mizuho set a target price of $70.0 on 11/14/2025
• Jason Kupferberg from Wells Fargo set a target price of $128.0 on 11/13/2025
• John Todaro from Needham set a target price of $190.0 on 11/13/2025

You can track data on $CRCL on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$DJT stock fell 15% this week, according to our price data from Polygon.

It has been the 40th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $DJT (you can track the company live on Quiver's $DJT stock page):

$DJT Insider Trading Activity

$DJT insiders have traded $DJT stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $DJT stock by insiders over the last 6 months:

• ERIC SWIDER has made 0 purchases and 2 sales selling 10,200 shares for an estimated $143,156.
• SCOTT GLABE (General Counsel and Secretary) purchased 1,000 shares for an estimated $10,465

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$DJT Hedge Fund Activity

We have seen 136 institutional investors add shares of $DJT stock to their portfolio, and 141 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 5,143,195 shares (+53.1%) to their portfolio in Q3 2025, for an estimated $84,451,261
• JANE STREET GROUP, LLC removed 4,715,253 shares (-34.1%) from their portfolio in Q3 2025, for an estimated $77,424,454
• YORKVILLE ADVISORS GLOBAL, LP removed 3,505,799 shares (-36.1%) from their portfolio in Q3 2025, for an estimated $57,565,219
• BLACKROCK, INC. added 3,039,036 shares (+64.3%) to their portfolio in Q3 2025, for an estimated $49,900,971
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,852,617 shares (+1139.3%) to their portfolio in Q3 2025, for an estimated $30,419,971
• HUDSON BAY CAPITAL MANAGEMENT LP removed 1,360,808 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $22,344,467
• GEODE CAPITAL MANAGEMENT, LLC added 1,150,214 shares (+63.1%) to their portfolio in Q3 2025, for an estimated $18,886,513

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

You can track data on $DJT on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$RGTI stock fell 6% this week, according to our price data from Polygon.

It has been the 44th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $RGTI (you can track the company live on Quiver's $RGTI stock page):

$RGTI Insider Trading Activity

$RGTI insiders have traded $RGTI stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.

Here’s a breakdown of recent trading of $RGTI stock by insiders over the last 6 months:

• MICHAEL S. CLIFTON has made 0 purchases and 6 sales selling 375,000 shares for an estimated $7,865,295.
• HELENE GAIL SANDFORD has made 0 purchases and 7 sales selling 104,635 shares for an estimated $3,682,913.
• THOMAS J IANNOTTI has made 0 purchases and 2 sales selling 200,000 shares for an estimated $3,619,890.
• RAY O JOHNSON has made 0 purchases and 2 sales selling 166,715 shares for an estimated $3,132,200.
• DAVID RIVAS (CHIEF TECHNOLOGY OFFICER) has made 0 purchases and 2 sales selling 86,290 shares for an estimated $1,763,027.
• JEFFREY A. BERTELSEN (CHIEF FINANCIAL OFFICER) has made 0 purchases and 2 sales selling 7,621 shares for an estimated $155,700.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RGTI Hedge Fund Activity

We have seen 310 institutional investors add shares of $RGTI stock to their portfolio, and 146 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• D. E. SHAW & CO., INC. added 12,764,516 shares (+inf%) to their portfolio in Q3 2025, for an estimated $380,254,931
• VANGUARD GROUP INC added 9,228,888 shares (+40.4%) to their portfolio in Q3 2025, for an estimated $274,928,573
• MAREX GROUP PLC removed 5,087,751 shares (-69.0%) from their portfolio in Q3 2025, for an estimated $151,564,102
• BLACKROCK, INC. added 4,489,029 shares (+21.3%) to their portfolio in Q3 2025, for an estimated $133,728,173
• PRICE T ROWE ASSOCIATES INC /MD/ added 4,201,228 shares (+663.8%) to their portfolio in Q3 2025, for an estimated $125,154,582
• TIDAL INVESTMENTS LLC added 2,377,981 shares (+99.9%) to their portfolio in Q3 2025, for an estimated $70,840,053
• SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 2,213,503 shares (-98.4%) from their portfolio in Q3 2025, for an estimated $65,940,254

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$RGTI Analyst Ratings

Wall Street analysts have issued reports on $RGTI in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wedbush issued a "Outperform" rating on 12/17/2025
• Mizuho issued a "Outperform" rating on 12/11/2025
• Benchmark issued a "Buy" rating on 11/12/2025
• Needham issued a "Buy" rating on 08/04/2025
• Cantor Fitzgerald issued a "Overweight" rating on 07/02/2025

To track analyst ratings and price targets for $RGTI, check out Quiver Quantitative's $RGTI forecast page.

$RGTI Price Targets

Multiple analysts have issued price targets for $RGTI recently. We have seen 7 analysts offer price targets for $RGTI in the last 6 months, with a median target of $35.0.

Here are some recent targets:

• Antoine Legault from Wedbush set a target price of $35.0 on 12/17/2025
• Kevin Garrigan from Jefferies set a target price of $30.0 on 12/16/2025
• Vijay Rakesh from Mizuho set a target price of $50.0 on 12/11/2025
• David Williams from Benchmark set a target price of $40.0 on 11/12/2025
• Craig Ellis from B. Riley Securities set a target price of $35.0 on 11/12/2025
• Quinn Bolton from Needham set a target price of $18.0 on 08/04/2025
• Troy Jensen from Cantor Fitzgerald set a target price of $15.0 on 07/02/2025

You can track data on $RGTI on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

$ASST stock fell 10% this week, according to our price data from Polygon.

It has been the 33rd most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $ASST (you can track the company live on Quiver's $ASST stock page):

$ASST Insider Trading Activity

$ASST insiders have traded $ASST stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ASST stock by insiders over the last 6 months:

• VIVEK RAMASWAMY purchased 15,625 shares for an estimated $1,250,000
• MATTHEW RYAN COLE (Chief Executive Officer) has made 4 purchases buying 515,195 shares for an estimated $415,998 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ASST Hedge Fund Activity

We have seen 44 institutional investors add shares of $ASST stock to their portfolio, and 13 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• YORKVILLE ADVISORS GLOBAL, LP added 37,037,037 shares (+inf%) to their portfolio in Q3 2025, for an estimated $92,592,592
• ANSON FUNDS MANAGEMENT LP added 35,250,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $88,125,000
• CITADEL ADVISORS LLC added 34,783,581 shares (+inf%) to their portfolio in Q3 2025, for an estimated $86,958,952
• ALYESKA INVESTMENT GROUP, L.P. added 33,750,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $84,375,000
• JANE STREET GROUP, LLC added 31,085,757 shares (+71660.8%) to their portfolio in Q3 2025, for an estimated $77,714,392
• MMCAP INTERNATIONAL INC. SPC added 18,518,519 shares (+inf%) to their portfolio in Q3 2025, for an estimated $46,296,297
• HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 14,814,815 shares (+inf%) to their portfolio in Q3 2025, for an estimated $37,037,037

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$ASST Analyst Ratings

Wall Street analysts have issued reports on $ASST in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Maxim Group issued a "Buy" rating on 12/10/2025

To track analyst ratings and price targets for $ASST, check out Quiver Quantitative's $ASST forecast page.

You can track data on $ASST on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.